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THE INFECTIOUS PARTICLE OF CRYPTOCOCCUS NEOFORMANS
CHAPTER I
INTRODUCTION AND LITERATURE REVIEW
Cryptococcus neoformans is an encapsulated yeast which is wide­
ly distributed in nature and causes a human infection called cryptococco­
sis, torulosis, or European blastomycosis. The organism has a pronounced 
predilection for the central nervous system, although it may cause a 
subacute or chronic infection involving skin, lungs, or other parts of 
the body (Littman and Zimmerman, 1956). It seems likely that minor, 
subclinical infections of the lungs are common and that only a small 
number of these infections progress into the disseminated state (Walter 
and Atchison, 1966; Davis, ^  al•, 1967; and Lewis, et , 1958). The 
increasing incidence of the latter form was noted by Aikat, Chatterjee 
and Banerjee (1967).
£. neoformans was discovered simultaneously by several investi­
gators. Sanfelice (1894) isolated a yeast-like organism from fermenting 
peach juice and demonstrated the pathogenicity of this organism for lab­
oratory animals. Owing to the "tumor-forming" ability of the organism, 
he named it Saccharomyces neoformans. Busse described the first human 
case, a localized infection, which later became generalized (1894, 1895). 
Curtis (1896) isolated a similar yeast-like organism from a myxomatous
2tumor of the hip. He named the organism tumefaciens. Vuillemin 
(1901) transferred these organisms into the genus Cryptococcus since they 
did not form ascospores. Weis (1902) compared the so-called "tumor- 
forming" yeasts with those isolated from milk and found that both types 
were pathogenic for experimental animals and quite similar in other 
aspects. Ironically, the first case of meningitis due to £. neoformans 
was not reported until 1905, at which time von Hansemann recovered yeast 
cells from a patient with tubercular meningitis (von Hansemann, 1905).
Currently, it is believed that cryptococcosis is caused only by 
C_. neoformans. The clinical forms are classified into five types; pul­
monary, central nervous system, dermal, osseous, and visceral (Emmons, 
Binford, and Utz, 1963).
According to Benham (1955, 1956), the genus Cryptococcus is 
characterized by; budding yeast cells, presence of a capsule, mucous cul­
ture which is yellow to yellow-brown in color; starch formation, absence 
of pseudo or true mycelium, absence of sugar fermentation (Kreger-van 
Rij, 1964), and urease production (Seeliger, 1956). Division of the 
genus into species is based upon the shape of the cells, assimilation 
reactions with various sugars and nitrate, growth at 37C, and patho­
genicity for mice. C_. neoformans has the following characteristics:
1. Thick walled, ovoid to spherical, 5-20y in diameter, budding 
yeast cells surrounded by a gelatinous capsule.
2. Assimilation of galactose, glucose, maltose, and sucrose.
Unable to assimilate lactose as sole source of carbon or ni­
trate as sole source of nitrogen.
3. Growth at 37C.
34. Pathogenicity for mice when injected intracerebrally or intra- 
peritoneally.
Cryptococcosis is a sporadic disease found throughout the 
world. Although spontaneous infections in animals have been reported, 
there are no known instances of animal-to-man or man-to-man transmission 
of the disease. Benham (1935) reported the isolation of Cryptococcus sp. 
from skin and feces of healthy individuals. This finding suggested an 
endogenous origin of cryptococcosis. However, Emmons in 1951 was the 
first to isolate this organism from the soil. Since then, this organism 
has been cultured from soils throughout the world, mainly from those con­
taining pigeon excreta (Ajello, 1958; Kao and Schwarz, 1957; Littman and 
Schneierson, 1959; Emmons, 1960; Bergman, 1963; Muchmore, £t a]^ ., 1963, 
Keall, Wilkie and Binns, 1968). Few workers currently hold to the en­
dogenous origin concept.
Emmons (1962), while studying sections of pigeon excreta con­
taining C^. neoformans, noted that the cells appeared nonencapsulated and 
produced very thin capsules when first isolated on laboratory media. 
Ishaq, Bulmer, and Felton (1968), reported that the capsule of a heavily 
encapsulated strain of C^. neoformans almost completely disappeared dur­
ing soil incubation. Their data indicated that, in conditions such as 
high humidity, lack of sunlight, and room temperature, £. neoformans 
remains viable in soil for periods in excess of one year. Their studies 
led them to speculate that the infectious particle of C_. neoformans may 
be nonencapsulated.
In man, the route of infection of the organism is believed to 
he respiratory. Freeman and Weidman (1923) isolated C^. neoformans from
4various tissues of guinea pigs after intranasal instillation of the 
cells. Wade and Stevenson (1941) inoculated mice intranasally with 
this organism and reported that several of the mice died of systemic 
cryptococcosis. Cox and Tolhurst (1946) infected one out of four mice 
by intranasal instillation. Ritter and Larsh (1963) demonstrated a 50 
percent mortality of white mice after intranasal instillation of about
10,000 viable cells of C_. neoformans. Subsequently, Smith and associ­
ates (1964) were able to infect white mice with an aerosol of the or­
ganism. Basu Mallik, et a^ . (1966) showed that, after white mice were 
exposed to a massive spray of C_. neoformans, a persistent lung infection 
developed. Invasion of blood occurred within 18 hours and the brain 
became involved after three days.
The role of pigeons and other birds in dissemination of cryp­
tococcosis has been a highly debatable subject. Emmons (1955) re­
ported that he was not able to isolate C^. neoformans from various organs 
and the digestive tract of birds. Staib (1962) isolated the organism 
from canary and other bird excreta. Littman, Borok, and Dalton (1965) 
were able to establish an infection in pigeons following intracranial 
inoculation of C_. neoformans. Littman and Borok (1968) fed C_. neofor­
mans to pigeons and were able to isolate viable cells from the gullet 
and excreta within the first one or two hours. Organisms were also 
recovered from the beaks, feathers, and feet. All of these reports 
seem to indicate that birds may be incidental carriers of £. neoformans,
i.e. they do not contjract cryptococcosis but may carry and disseminate 
viable yeast cells on external portions of their body or pass it in 
excreta after ingestion of contaminated materials.
5Perhaps one of the most outstanding characteristic of organisms 
of the genus Cryptococcus is the ability to produce a capsule. The cap­
sule may be five times the diameter of the cell, especially in tissues. 
While many pathogenic bacteria possess capsules, C_. neoformans is the 
only encapsulated pathogenic yeast. The relationship of capsules to 
bacterial pathogenicity has been known for many years and it is gener­
ally accepted that the capsules of pathogenic bacteria fall into three 
categories (MacLeod and Bernheimer, 1965):
1. Nontoxic, antigenic capsules that act by inhibiting phagocy­
tosis, and antibodies produced against the capsule are pro­
tective. The best example of an organism possessing this type 
of capsule is Diplococcus pneumoniae, in which isolated, type 
specific, pneumonoccal capsule inhibits phagocytosis vitro, 
and when injected into animals it induces the production of 
specific antibody which subsequently protects the animal 
against that specific type of D^. pneumoniae (MacLeod and 
Krauss, 1950).
2. Nontoxic, antigenic capsules that act by inhibiting phagocy­
tosis, but antibodies against the capsule are not protective. 
One of the best examples of an organism in this category is 
Bacillus anthracis. In this case, the capsule inhibits phago­
cytosis vitro, but the antibodies produced against it are 
not protective in vivo (Smith and Keppie, 1955).
3. Nontoxic, nonantigenic capsules which inhibit phagocytosis.
The hyaluronic acid capsule of streptococci of Group A is an 
example of this category. While hyaluronic acid is antiphago­
cytic vitro, it is recognized as "self" vivo, and thus
no antibody is produced against. (Kass, and Seastone, 1944).
Serologic differences between strains of C^. neoformans were 
first reported by Benham in 1935. After studying several strains of the 
organism by means of serological tests and virulence assays, she divided 
them into two types. Later, Evans (1949), on the basis of agglutinin 
titers, divided 12 strains of C. neoformans into three serotypes. A, B, 
and C. He showed that type specificity was due to the capsular poly­
saccharide. More recently, Walter and Atchison (1966), Vogel (1966), 
and Wilson, Bennett, and Bailey (1968) presented evidence which suggests 
that at least four different serotypes exist in C_. neoformans.
C^. neoformans produces a minimal and variable immunological re­
sponse in diseased humans. Several investigators (Shapiro and Neal, 1925; 
Kimball, Hasenclever, and Wolff, 1967) failed to demonstrate any type of 
antibody production in diseased humans, while others (Rappaport and 
Kaplan, 1926; Vogel, Sellers, and Woodward, 1961) demonstrated antibody 
in patients' sera using agglutination and indirect fluorescent antibody 
techniques. Bloomfield, Gordon, and Elmendorf (1963) and Gordon and 
Veddar (1966), using antibody-sensitized latex particles in the slide 
agglutination test and yeast cell agglutination, detected antigen and/or 
antibody in the sera of patients suffering from cryptococcosis. The 
antigen detected in patients with cryptococcosis may be composed largely 
of cryptococcal capsular polysaccharide. Neill, Sugg, and McCauley 
(1951), using anticryptococcal antibody in precipitin and complement 
fixation tests, detected serologically active "soluble antigens" in the 
spinal fluid, blood, and urine of a patient with cryptococcal meningitis. 
Absorption of antiserum with cryptococcal polysaccharide removed the
7capacity of the serum to react with the fluids of the patient.
In experimental animals, the immune response varies consider­
ably among different species and with the type of antigen used. Neill, 
Abrahams and Kapros (1950) showed that killed, weakly encapsulated 
cells of C. neoformans were a better immunogen than killed, heavily 
encapsulated cells. Comparisons of the antibody responses included 
not only agglutination of the cells, but also precipitation of crypto­
coccal polysaccharide and "quellung" reaction on the heavily encapsu­
lated cells. However, this phenomenon differs from that seen with the 
pneumococci in that it appears to be due to a change in the capsule 
which makes it more readily seen, rather than to an increase in the 
size of the capsule (Neill, et ^ . , 1949). Evans, (1956) sug­
gested that visualization of the Cryptococcus capsule may be due to the 
formation of a thin line of precipitation around the capsule. Kase and 
Metzger (1962), using a dry variant of C_. neoformans, reported the pro­
duction of high titers of antibody (1:640 to 1:1280) to different anti­
genic preparations of £. neoformans which contrasts with the minimal 
antibody responses obtained by most investigators. Devlin and Patnode 
(1968) showed that cryptococcal antigens prepared by zeolite treatment 
of formalized yeast cells were quite antigenic and produced a strong 
humoral antibody response in rabbits. Gadebusch (1963) reported that 
the injection of purified cryptococcal capsular polysaccharide into 
rabbits resulted in the production of specific anticapsular antibody. 
Other investigators (Cozad, Richey, and Larsh, 1963; Devlin, 1969), 
however, presented strong evidence to the contrary. Goren and 
Middlebrook (1967) demonstrated that cryptococcal polysaccharide
conjugated to bovine gamma-globulin is a potent antigen for mice. How­
ever, Goren (1967) found that such antibodies were not protective.
Bennett and Hasenclever (1965) demonstrated the persistence of capsular 
material in the blood of rabbit and mice for several weeks. The ani­
mals were susceptible to subsequent inoculation with viable yeast cells. 
Thus, it seems that cryptococcal capsular material, while not immuno­
genic, is haptenic and that antibodies produced against it are not pro­
tective.
Whereas the importance of bacterial capsules as virulence 
factors has been amply documented, the importance of the cryptococcal 
capsule remained rather obscure until recently, when Bulmer, Sans, and 
Gunn (1967), using encapsulated parental cells and nonencapsulated mu­
tants of C. neoformans, showed a correlation between the presence of 
capsule and the virulence of the organism for mice.
One of the first reports on the effect of cryptococcal capsule 
on leukocytes was that presented by Drouhet and Segretain in 1951. They 
reported that the cryptococcal capsule inhibited the migration of guinea 
pig leukocytes in vitro. Gadebusch (1958, 1959) demonstrated that a 
small-capsule variant of C^.. neoformans was phagocytized more readily 
than a heavily encapsulated variant by leukocytes from anemic mice.
Louria and Kaminski (1965), as a result of studies with small- and large- 
capsule strains, suggested that the immunity to cryptococcal infection 
in mice was "tissue bound". Abrahams (1966) reached similar conclusions. 
Bulmer and Sans (1967, 1968) demonstrated that isolated cryptococcal 
polysaccharide inhibited the phagocytosis of the organism by human peri­
pheral leukocytes in vitro. Later, Bulmer, Farhi, and Tacker (in
9preparation) demonstrated intracellular killing of C_. neoformans by 
peripheral blood leukocytes.
The cryptococcal capsule appears to have the following effects 
on the host:
1. Isolated cryptococcal capsule inhibits the phagocytosis of 
C_. neoformans. The antiphagocytic nature of the material is 
very specific and results from the adherence of the material 
to the yeast cells. Isolated capsule does not effect leuko­
cytes, since it does not inhibit the phagocytosis of other 
microorganisms (Bulmer and Sans, 1968).
2. Inoculation of the material along with unrelated immunogens 
does not inhibit antibody production (Devlin, 1969).
3. Although it has been shown that a soluble fraction released 
from cryptococcal cells, as well as whole cells, produces a 
fever response in rabbits (Briggs and Atkins, 1966; Haley,
Myer, and Atkins, 1966), it was shown by the same investiga­
tors that small amounts of purified polysaccharide are non- 
pyrogenic for rabbits. The minimal pyrogenic dose of the 
yeast polysaccharide appeared to be 10-20 mg, whereas 0.0003-
0.03 mg of purified lipipolysaccharide from gram-negative bac­
teria produced the same response in rabbits (Landy, et al., 
1955; Snell and Atkins, 1965).
Thus, it would appear that the cryptococcal capsule is nontoxic 
and antiphagocytic, and that the antibody produced against it is not 
protective.
The cryptococcal capsule is a polysaccharide. Evans and Kessel
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(1951) showed that the polysaccharide contains hexose, pentose, and hex- 
uronic acid. Evans and Mehl (1951), using paper chromatography, identi­
fied galactose, mannose, xylose, and hexuronic acid. These investigators 
suggested that the difference between serotypes was due to quantitative 
rather than qualitative changes in the amount of different monomers pre­
sent in capsular polysaccharide. Drouhet, Segretain, and Auber (1950) 
reported the presence of only mannose, xylose, and glucuronic acid in 
cryptococcal polysaccharide, although they suggested that the capsule 
may contain a hyaluronic acid-like substance (Drouhet and Segretain,
1949). Foley and Uzman (1952) isolated a highly polymerized capsular 
polysaccharide from C^. neoformans by hot alkali and were unable to de­
tect hyaluronic acid-like substances. Einbinder, Benham, and Nelson 
(1954) reported that the capsular polysaccharide of C_. neoformans con­
tained 31 percent pentose (arabinose), 18.1 percent hexose (glucose), 
and 6.1 percent hexuronic acid (glucuronic acid). Rebers, e_t a]^ . (1958), 
using antibody absorption techniques concluded that the capsular side 
chains terminate in galactose and glucuronic acid in Type A C^. neoformans. 
They also suggested that the cryptococcal polysaccharide may contain at 
least two types of polymers. Miyazaki (1961) proposed a branched mannose 
backbone for an untyped _C. neoformans. Blandamer and Danishefsky (1966) 
reported molar ratios of mannose to xylose and glucuronic acid to gal­
actose to be 6:4 and 2:1, respectively for Type B _C. neoformans. Their 
findings on the composition of oligosaccharide, obtained by partial 
hydrolysis of native polysaccharide, and the rate of release of the 
specific monosaccharides suggested that cryptococcal polysaccharide con­
sists of a mannan backbone with branches of xylose and glucuronic acid.
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The objectives of this investigation were to study:
1. The effect of soil incubation on cells and capsules of £. 
neoformans.
2. The conditions under which capsular production by environ­
mentally or genetically induced nonencapsulated cells of C_. 
neoformans is initiated.
3. The chemical nature of capsular and soluble polysaccharides 
produced by C_. neoformans.
4. The time required for the cells of £. neoformans to produce 
enough capsular material in human tissues to impair phagocy­
tosis by human leukocytes.
CHAPTER II 
MATERIALS AND METHODS
The eight encapsulated strains of Cryptococcus neoformans (CIA, 
A, B, CDC, CS, CSIO, UHl, UH3) used in these studies were obtained from 
Dr. Glenn S. Bulmer, Department of Microbiology, University of Oklahoma 
School of Medicine. All of these organisms were human isolates except 
for CS and CSIO which were cultured from soil. Strain CIA was classi­
fied in serotype A by J. Walter (personal communication). Methods for 
obtaining mutants and culturing neoformans in a nonencapsulated state 
are described below. Unless otherwise stated, strain CIA was used for 
these investigations. Stock cultures of all strains were transferred 
weekly on Sabouraud-Dextrose broth plus 2% agar (Difco).
Animals
White mice, 4-8 weeks of age, obtained from the University of 
Oklahoma Medical Center, were used in virulence, transformation and cap­
sular production studies.
Soil Sample
Soil, used for incubation of C_. neoformans was collected from 
Kingfisher, Oklahoma and obtained from the laboratory of Dr. F. Felton, 
Veterans Administration Hospital, Oklahoma City, Oklahoma.
12
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Media
Bacto-Yeast Nitrogen Base Without Amino Acids (Difco)
This medium was supplemented with 5.0pg/ml thiamine monochlo­
ride and 1.0 mg/ml sodium glutamate. One percent (final concentration) 
of the following was added; D-galactose, D-glucose, D-sodium glucuronate, 
D-lactose, D-maltose, D-mannose, sucrose, and D-xylose.
Bacto-Yeast Carbon Base (Difco)
This medium was supplemented with 5.0 yg/ml of thiamine mono- 
chloride and 5.0 mg/ml of sodium nitrate.
Essential Salt Solution (ESS)
ESS was prepared by dissolving the following in 100 ml of dis­
tilled water: KHgPO^, 2.0 gm; (NH^)2S0^, 2.0 gm; MgCl.ôH^O, 0.2 gm;
CaCl2.2H20, 0.002 gm; FeCl2.4H20, 0.04 gm; MnCl2.4H20, 0.0015 gm; and 
NaNOS, 0.0015 gm.
Low pH Synthetic Medium (LpH)
LpH was prepared by adding 0.02 gm/ml glucose and 5.0 yg/ml 
thiamine monochloride to a 1:10 dilution of ESS. Hydrochloric acid 
(O.IN) was used to adjust the pH to 5.0. This medium allows the growth 
of C^. neoformans without the production of capsule.
High pH Synthetic Medium (HpH)
This medium was prepared by adding 0.01-0.03 gm/ml glucose,
0.1 mg/ml sodium glutamate, and 5.0 yg/ml thiamine to a 1:10 dilution 
of ESS. The pH of the medium was adjusted to 7.0 with O.IN NaOH. In 
this medium C. neoformans produces a large capsule.
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Other Media
Sabouraud dextrose broth (hereafter referred to as Sabouraud 
medium), trypticase soy agar (Difco), potato-dextrose agar (Difco), and 
Raper's complete agar (Raper, 1966) were also used. In all instances,
2% agar was added when solid medium was desired.
India Ink Measurement of the Capsule 
Unless otherwise stated, the size of the capsules of £. neofor­
mans was measured by mixing a drop of yeast cell suspension on a micro­
scope slide with a drop of Higgins American India Ink diluted 1:2 with 
distilled water. After the addition of a cover slip, 100 cells were 
viewed microscopically and the number of encapsulated and nonencapsulated 
cells was counted and converted into percentages. A Porton Ritcle Ocular 
micrometer was used for microscopic measurements. The diameter of the 
capsule of encapsulated cells was determined by subtracting the diameter 
of the cell from the diameter of the cell plus capsule.
Incubation of C^. neoformans in Soil 
The suspensions of C_. neoformans used to inoculate the soil 
were prepared in the following manner: one hundred and fifty ml of water 
were added to 25 gm soil and stirred for 30 minutes on a magnetic stirrer 
(Fisher Scientific Co. Model 14-511-1). After centrifugation at 350 x g 
for 15 minutes, the supernatant fluid was removed and autoclaved. Cells 
of _C. neoformans, cultured for 48 hours on HpH agar, were added to 15 ml 
of the sterile soil washings to give the following concentrations: Strain
o 8 9
CIA, 1.2 X 10 (preliminary study) and 4.2 x 10 ; strain A, 1.2 x 10 ;
Q 8 8
strain B, 3.5 x 10 ; strain CDC, 3.0 x 10 ; strain CS, 2.5 x 10 ; strain
15
CSIO, 5.3 X 10^; strain UHl, 1,6 x 10^; and strain UH3, 1.5 x 10^. Con­
trol bottles received 0.2 ml of autoclaved encapsulated yeast cells.
Five gm of soil was added to each of 500 screw capped bottles 
( 3 x 3 x 5  cm.) which were divided into 8 groups. Bottles in each group 
received 0.2 ml of a suspension of one of the eight strains of £. neo­
formans. All bottles were shaken manually to disperse the yeast cells 
throughout the soil and were then incubated at 25C in a dark incubator 
having a humidity of 85%.
At various time intervals, two bottles from each set were re­
moved from the incubator. Ten ml of sterile water were added to each 
bottle. The bottles were shaken manually for 2 minutes and allowed to 
stand at 25C for 5 minutes; viable plate counts and India ink prepara­
tions were made with samples removed from the supernatants to determine 
the number of viable cells in each bottle, the percent encapsulated and 
nonencapsulated cells, and the diameter of the capsule and cells.
Capsular Production of £. neoformans 
After One Year Incubation in Soil
The following experiments were carried out using 4 bottles of 
soil containing cells of CIA which had been incubated in soil for one 
year. To each bottle 10 ml of distilled water was added and yeast cell 
suspensions were prepared as described previously. The suspensions 
were pooled and 0.5 ml was added to 24 test tubes (13 x 100 mm) in the 
following experimental systems: The first system contained six tubes;
2 tubes contained 2.0 ml of HpH broth, 2 tubes contained 2.0 ml of Sab­
ouraud broth, and 2 tubes containing 2.0 ml of distilled water. All 
tubes received 0.5 ml of water. The second system contained 6 tubes and
16
was a replica of the first system with the exception that all tubes re­
ceived 0.5 ml of chloroform instead of 0.5 ml of water. The third sys­
tem consisted of six tubes each containing 2 ml of 0.1 M glucose and the
following concentrations of dinitrophenol (DNP, Fisher Scientific Com-
—U “5 —A
pany, Fair Lawn, N.J.), 10 M, 10 M and 10 M. Four additional bottles
containing cells of CIA which had been incubated in soil for one year 
were autoclaved for 30 minutes. A cell suspension was prepared by add­
ing 10 ml of sterile water to each of the autoclaved bottles and manu­
ally shaking the bottles for two minutes. After 5 minutes without shak­
ing, the supernatant fluids from the bottles were pooled and used as 
inocula (0.5 ml/tube) for two tubes containing 2.0 ml of HpH broth, two 
tubes containing 2.0 ml of Sabouraud broth, and two tubes containing
2.0 ml of sterile distilled water.
All 24 tubes were incubated on a rotator (Multi-Purpose Rotator, 
Model 150V, Scientific Industries, Inc., Springfield, Mass.) at a speed 
of 15 rpm for 24 hours at 25C, at which time India ink preparations of 
each sample were made a..d the percent encapsulation and diameter of the 
cells and capsules were determined.
Virulence of £. neoformans Incubated in Soil 
After 0, 1, 6, 12, and 18 months incubation in soil, cells of 
CIA were collected as described previously and 1.0 ml samples were in­
jected intraperitoneally into each of the five mice. The number of cells 
inoculated into each animal varied from 0.79 x 10^ to 4.3 x 10^. Four 
weeks post-inoculation, the brains of infected mice were examined by 
direct microscopy for the presence of encapsulated yeast cells, using 
India ink preparations, and by culturing the tissues on Sabouraud agar
17
plates. After 3-5 days incubation at 25C, the plates were examined for 
the presence of encapsulated yeast colonies.
Effect of Water on Capsular Production by C_. neoformans 
Incubated in Soil for One Year
Various amounts of distilled water, 0.5, 1.0, 1.5, 2.0, 2.5,
3.0, 4.0, and 5.0 ml, were added to 5 gm soil samples containing cells 
of CIA incubated for one year. Control samples were autoclaved for 30 
minutes before the addition of water. After 72 hours incubation at 25C, 
the yeast cells were examined in India ink preparations for the percent 
encapsulation and size of the capsule.
Generation Time of C^. neoformans Grown on Laboratory 
Medium and Incubated in Soil
Cells of CIA grown on Sabouraud agar for 48 hours were harvested 
and suspended in 10 ml of sterile distilled water. To a 250 ml Erlen- 
meyer flask was added 50 ml of HpH broth containing 2% glucose. One ml 
of the cell suspension was added to the medium to give a final concentra­
tion of 5 X 10^ cells/ml.
Cells of CIA, incubated in soil' for one year, were harvested 
as soil washings, as described previously. To 50 ml of HpH broth con­
taining 2% glucose was added 1.0 ml of the soil washing cell suspension 
to give a final concentration of 7 x 10^ cells/ml.
Both cultures were incubated at 25C under aeration. After 2,
4, 6, 8, 20, 28, 36, 44, 52, and 64 hours, samples were removed and the 
number of viable cells was determined by dilution plate counts on Sab­
ouraud agar. Generation time was calculated from the following formula:
0.3010t
G = log^ gb - log^ a^
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Where G is generation time, t is time elapsed, 0.3010 is log^^ of 2, b 
is the number of bacteria at the end of t, and a is the number of bacteria 
at the beginning of t (Oginsky and Umbreit, 1959).
Environmentally Induced Nonencapsulated 
Cells of C. neoformans
Cells of CIA were cultured on LpK agar at 26C to obtain environ­
mentally induced nonencapsulated cells. After 2-3 subculturings at 3-5 
day intervals, 95% of the cells produced very small, or no, capsules 
as observed in India ink preparations.
Capsular Production by Environmentally Induced 
Nonencapsulated Cells of C_. neoformans
Forty-eight hour cultures of nonencapsulated cells, grown on
LpH agar, were harvested, suspended in 50 ml of 0.3 M phosphate buffer
(pH 5.0), and shaken overnight on a horizontal shaker (Burrell Wrist
Shaker). The suspension was then centrifuged at 300 x g for 30 minutes.
The supernatant fluid was discarded and the cells were resuspended in
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sterile distilled water to a concentration of 1-2 x 10 cells/ml. One 
tenth ml of this suspension was added to each of the systems shown in 
Table 1, Table 2, and Table 3, in attempts to study the time and sub­
strates required for capsular production, the effect of different con­
centrations of thiamine on initial capsular production, and the effect 
of the following metabolic inhibitors on capsular production; sodium 
fluoride (NaF, J. T. Baker Chemical Co., Phillipsburg, N.J.), potassium 
iodoacetate (KIAc, Eastman Organic Chemicals, Rochester, N.Y.), and DNP. 
All systems were incubated on a horizontal shaker at 25C. After 0, 1,
3, 5, 7, 10, 18, and 24 hours, samples were removed for assay of cell
TABLE 1
PROTOCOL USED TO STUDY THE EFFECT OF VARIOUS 
SUBSTRATES ON CAPSULAR PRODUCTION
Constituents of Each Flask^
Flask 
No.
ESS^
(ml)
Glucose 
(0.1 gm/nil) 
(ml)
Glutamate 
(0.02 gm/ml) 
(ml)
Thiamine 
(50 pg/ml) 
(ml)
(NH4) SO, 
(0.02 gm/ml) 
(ml)
H O
(ml)
1 2.0 2.0 2.0 2.0 2.0 10.0
2 2.0 - 2.0 2.0 2.0 12.0
3 2.0 - - 2.0 - 16.0
4 2.0 - - 2.0 2.0 14.0
5 2.0 2.0 - - 2.0 14.0
6 2.0 2.0 - - - 16.0
All solutions were prepared in distilled HgO. The pH was adjusted to 7.0 with 0.1 N NaOH 
prior to sterilization.
Essential Salt Solution
TABLE 2
PROTOCOL USED TO STUDY THE EFFECT OF VARIOUS CONCENTRATIONS 
OF THIAMINE ON CAPSULAR PRODUCTION
Constituents of Each Flask^
Flask 
No.
ESS^
(ml)
Glucose 
(0.1 gm/ml) 
(ml)
Glutamate 
(0.02 gm/ml) 
(ml)
Thiamine 
(100 pg/ml) 
(ml)
(NH ) SO4 
(0.02^gm/ml)
(ml)
H O
(ml)
1 2.0 2.0 2.0 0.0 2.0 12.0
2 2.0 2.0 2.0 0.2 2.0 11.8
3 2.0 2.0 2.0 0.4 2.0 11.6
4 2.0 2.0 2.0 0.5 2.0 11.5
5 2.0 2.0 2.0 1.0 2.0 11.0
roo
All stock solutions were prepared In distilled H2O. The pH was adjusted to 7.0 with O.IN 
NaOH prior to sterilization.
Essential Salt Solution
TABLE 3
PROTOCOL USED TO STUDY THE EFFECT OF VARIOUS METABOLIC 
INHIBITORS ON CAPSULAR PRODUCTION
Constituents of Each Flask^
Flask
No.
ESS^
(ml)
Glucose 
(0.1 gm/ml) 
(ml)
Glutamate 
(0.02 gm/ml) 
(ml)
Thiamine 
(50.0 pg/ml) 
(ml)
(NH4) SO4 
(0.02 gm/ml) 
(ml) Inhibitor
H„0
(ml)
1 2.0 2.0 2.0 2.0 2.0 — 10.0
2 2.0 - 2.0 2.0 2.0 — 12.0
3 2.0 2.0 2.0 2.0 2.0 KIAc 8.0
4 2.0 2.0 2.0 2.0 - KIAc 10.0
5 2.0 2.0 2.0 2.0 2.0 NaF 8.0
6 2.0 2.0 2.0 2.0 - NaF 10.0
7 2.0 2.0 2.0 2.0 2.0 DNP 8.0
8 2.0 2.0 2.0 2.0 - DNP 10.0
All stock solutions were prepared in distilled H„0. Final concentration of the inhibitors 
was; KIAc, 1 x 10 M; NaF, 1 x 10~^M, and DNP, 1 x 10“^M. The pH was adjusted to 7.0 with O.IN NaOH
prior to sterilization, 
b.Essential Salt Solution
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viability, as measured by the dilution plate count method and the trypan 
blue method (McLimans, et , 1957). Percent encapsulation as observed 
microscopically in India ink preparations.
Effect of Various Carbohydrates on Capsular 
Production by Nonencapsulated Resting 
Cells of C. neoformans
Cells of CIA were cultured for 48-72 hours on LpH agar and 
harvested by suspending the cells in sterile distilled water. After two 
washings with sterile distilled water, the cells were suspended in sterile
g
distilled water to a concentration of 1-2 x 10 cells/ml. Aliquots (0.2 
ml) of this suspension were added to test tubes containing 2.0 ml 0.85% 
NaCl (saline), O.IM KH^POA and 1.0% (final concentration) of either gal­
actose, glucose, glucuronic acid, mannose or xylose. Control tubes con­
tained no carbohydrate. The tubes were incubated at 25C on a rotator. 
After 18 hours incubation the size of the capsules and the percent en­
capsulation was measured in India ink preparations. The percent viabil­
ity of the cells was determined with trypan blue.
Optimal pH for Capsular Production by Nonencapsulated 
Resting Cells of £. neoformans
Three different buffers, Walpole's acetate buffer (pH range of 
3.6-5.6), Sorenson's phosphate buffer (pH range of 5.0-8.2), and 
Mcllvaine's citrate phosphate buffer (pH range of 2.2-8.0) were used to 
assay for the optimal pH range of capsular production by resting cells 
of _C. neoformans (Diem, 1968). The inoculum was prepared from a 24-48 
hour culture of cells of CIA grown on LpH. The cells were incubated in 
0.3M phosphate buffer (pH 5.0) at 25C for 4-5 hours, removed by centri­
fugation at 300 X g for 30 minutes, and resuspended in sterile distilled
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water to concentration of 1-2 x 10 cells/ml. Each tube contained 3.0 ml 
of a given buffer (pH range of 3.0 to 8.2, in 0.4 increments), 0.1 ml of 
a 33% glucose solution, and 0.1 ml of cell inoculum. At various time 
intervals, samples were removed and the percent encapsulation, capsular 
diameter, and viability were determined. The India ink used for de­
tecting capsular production at pH values under 5.0 was buffered with 
Sorenson's phosphate buffer at pH of 8.0 to prevent aggregation of 
India ink.
Incubation of Nonencapsulated Cells of C_. neoformans 
with Cryptococcal Polysaccharide
Cells of CIA, grown on LpH agar for 3 days at 25C, was used as 
inoculum. Medium was prepared consisting of Bacto-Yeast Nitrogen Base 
supplemented with 1.0 mg/ml of capsular polysaccharide (ACIA) isolated 
from encapsulated CIA cells (See below. Isolation of Adhered Capsular 
Polysaccharide of C. neoformans, CIA) as a sole source of carbon. To 
50 ml of medium in each of two 125 ml Erlenmeyer flasks was added cryp­
tococcal cells to a final concentration of 1-5 x 10^ cells/ml. The 
flasks were incubated at 25C, one flask without aeration and the other 
under aeration. After 0, 1, 3, 5, 7, 14, 21, and 28 days, 2.5 ml sam­
ples were removed. A 0.5 ml portion was dilution-plated and the remain­
ing 2.0 ml was passed through a millipore filter (HAWP 025 00 HA 0.45y). 
The filtrate was dialyzed at 40 against 4 changes of tap water and 3 
changes of distilled water and then the total carbohydrates were deter­
mined. For this purpose, the nondialyzable solution was diluted 
1:5 with distilled water and 1.0 ml of this material was used with 2.0 
ml of Anthrone reagent (Seifter, e^ , 1950). The quantity of
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carbohydrate present in each sample was determined by reading in a 
Beckman DU spectrophotometer at 620 mp. A standard curve was prepared 
using known concentrations of ACIA polysaccharide.
Effect of Inorganic Salts on Capsular Production 
by Growing Cells of C. neoformans
Sabouraud broth and HpH broth were used to study the effect of 
NaCl on capsular production. The media were supplemented with 0, 1, 3, 
5, 7, and 10% NaCl. The inocula consisted of either encapsulated or 
environmentally induced nonencapsulated cells of CIA. To 5.0 ml of 
each of the media was added 0.1 ml of distilled water containing 1-2 x 
10^ cells. The tubes were incubated on the rotator at 25C. After 1,
3, 5, and 7 days, samples were removed and observed in India ink pre­
parations for the presence of capsule and tested for viability with 
trypan blue dye and by recording turbidity at 690 mp in a Bausch and 
Lomb Spectronic 20.
In further experiments, encapsulated cells of six strains of 
£. neoformans were cultured in HpH broth containing 5% (final concen­
tration) of either NaCl, NaNO^, Na2S0 ,^ KCl, KH^PO^, or KgHPO^.
Percent encapsulation was determined in India ink preparations after 
the organisms had been subcultured twice at 43-72 hour intervals.
Effect of Lactose on Capsular 
Production by C^. neoformans
To study the effect of various concentrations of lactose on 
capsular production of CIA, HpH broth was supplemented with 0, 5, 10, 
20, 30, and 40% lactose. To 5.0 ml of each of the concentrations of 
lactose was added 0.1 ml (1-3 x 10^ cells) of an aqueous suspension of
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CIA cultured on LpH. The tubes were incubated at 25C on a rotator. 
After 0, 1, 2, 4, and 7 days, samples were removed and the percent en­
capsulation and growth were determined by India ink preparations and 
tuxbidimetric techniques, respectively.
Capsular Production by C^. neoformans 
Grown on Various Media
Capsule production by 8 strains of _C. neoformans cultured on 
nutrient agar, trypticase soy agar, HpH agar, Sabouraud agar, potato-
dextrcse agar and Raper's complete agar was determined. Each strain
was inoculated onto each of the media and incubated at 25C for 72-96 
hours. After 3 subculturings the size of the capsule was measured in 
India ink preparations.
Capsular Production by C_. neoformans
in Mouse Tissue In Vitro
Cardiac blood was collected from 8 week old mice and pooled 
in a heparinized tube. Brains and lungs of the animals were removed
3
and cut into approximately 0.5 cm pieces. Various combinations (Table 
4) of lung, brain, blood, saline, and HpH broth were inoculated with 
1-2 X 10^ nonencapsulated cells of CIA which had been cultured on LpH 
agar. The tubes were incubated on a rotator at 37C. At various time 
intervals,-capsular production was measured in India ink preparations. 
For this study, India ink was prepared in phosphate buffer (pH 8.0) 
to reduce aggregation of ink particles. A similar protocol was used to 
study the ability of nonencapsulated mutants, and S^, to produce 
capsules in mouse tissue i^ vitro.
TABLE 4
PROCEDURE USED TO STUDY CAPSULAR PRODUCTION BY 
C^. NEOFORMANS, CIA, IN MOUSE TISSUES IN VITRO*
Tube 
No.
Blood
(ml)
Brain
(mm^)
Lung
(mm^)
0.85% NaCl 
(ml)
HpH Broth 
(ml)
1 0.5 0.5 - — 1.0
2 0,5 - 0.5 0.5 -
3 — - 0.5 0.5 -
4 0.5 0.5 — 0.5 -
5 — 0.5 — 0.5 -
6 — — ! - 1.0
to
cr\
*A11 tubes were inoculated with 1-2 x 10 nonencapsulated cells of C^. neoformans, CIA, which 
had been cultured on low pH synthetic agar (LpH).
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Isolation of Nonencapsulated Mutants 
of £. neoformans
Spontaneous, nonencapsulated mutants of strain CIA were isolated 
by a method similar to that described by Goodlaw, Mika, and Braun (1950) 
for the isolation of nonencapsulated mutants of Brucella abortus. Sab­
ouraud broth (100 ml) was inoculated with a heavy suspension of a 48 
hour culture of encapsulated cells grown on HpH and incubated at 25-27C 
in a stationary state. Samples were taken at three day intervals, for 
a period of 4 weeks and plated onto Sabouraud agar. Cells from dry, 
rough appearing colonies were isolated and examined in India ink pre­
parations for the presence of a capsule. Nonencapsulated isolates were 
characterized auxanographically and by the tube assimilation techniques 
as to their ability to utilize galactose, glucose, lactose, maltose and 
sucrose and nitrate (Ajello, e_t _al., 1966). The ability to produce 
urease was determined by using urea disks (Difco). Further character­
ization of these mutants as to their ability to utilize various mono­
mers of cryptococcal capsule, i.e., galactose, glucuronic acid (potas­
sium salt), mannose, and xylose, was done by culturing the cells on 
Bacto-Yeast Nitrogen Base supplemented with 2% agar and 1% of each of 
the above sugars. Cells were transferred at least three times on each 
medium.
The virulence of the mutants and the parental strains was deter­
mined by inoculating eight weeks old mice intraperitoneally (I.P.) with
1.0 ml of a saline suspension containing 1-3 x 10^ cells or by inocula­
ting 4-6 week old mice intracerebrally (I.C.) with 0.05 ml of a saline
g
suspension containing 1-3 x 10 cells/ml. Ten mice were inoculated with 
each strain and observed for 9 months. Surviving animals were sacrificed
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and brain, lung, spleen and liver of all were homogenized using mortar 
and pestle and examined by direct microscopy for the presence of yeast 
cells using India ink preparations, and by culturing the tissues on 
Sabouraud agar. Animals which expired were examined in a similar manner.
Transformation Studies 
A method similar to that of Griffith (1928) was used. Eighteen 
mice were injected I.P. with 1.0 ml of a mixture containing 1 x 10^ cells 
of heat-killed (autoclaved for 10 minutes) encapsulated cells of CIA and 
1-2 X 10^ cells of one of the nonencapsulated mutants, S^, S^, or S^ (See 
Chapter III for characteristics of these mutants). Two mice were sacri­
ficed at 1, 3, 5, 7, 9, 11, 13, 15 and 20 days. Lung, brain, kidney, 
and blood were removed, homogenized, and plated onto Sabouraud agar.
After 3-10 days incubation at 25C, the plates were examined for the pre­
sence of colonies of encapsulated yeast.
Isolation of Soluble Polysaccharide 
From C_, neoformans
Three liters of HpH broth, supplemented with 3% glucose, were 
inoculated with 50 ml of a 48 hour culture of either CIA or the mutants,
S^ and S^. After 96 hour incubation at 25C, under aeration, the cells 
were killed by the addition of 3% chloroform (final concentration), and 
removed by centrifugation at 300 x g for 30 minutes. Sodium acetate 
(10%), acetic acid (1%), and two volumes of absolute ethanol were added 
to the supernatant fluid. The mixture was stored at 4C for 48 hours. The 
precipitate was collected following centrifugation at 300 x g for 15 min­
utes. One volume of absolute ethanol was. added to the supernatant fluid 
and the mixture was stored at 4C for 48 hours. The precipitate was then
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collected following centrifugation at 300 x g for 15 minutes. No addi­
tional precipitate could be obtained by the further addition of ethanol 
to the supernatant fluid. The two precipitates were pooled, washed in 
200 ml of absolute ethanol, centrifuged at 300 x g for 15 minutes, and 
resuspended in distilled H^O to give a 1% solution. The material was 
then centrifuged at 22,000 x g for 60 minutes at 40 to remove insoluble 
impurities. The supernatant was deproteinized by 8 extractions with 
chloroform and n-butanol (4:1 v/v, Sevag, Lackman, and Smolens, 1938).
To the deproteinized supernatant fluid were added sodium acetate (10%), 
acetic acid (1%), and 3 volumes of absolute ethanol. After 48 hours 
incubation at 4C, the precipitate was collected following centrifuga­
tion at 300 X g for 15 minutes, and dissolved in water, dialyzed against 
4 changes of tap water and 4 changes of distilled water at 4C. After 
lyophilization, the material was stored at room temperature. The iso­
lated polysaccharides are hereafter referred to as: S^, soluble poly­
saccharide isolated from cells; S^ , soluble polysaccharide isolated 
from cells; and SCIA, soluble polysaccharide isolated from cells of 
CIA.
Isolation of Adhered Capsular Polysaccharide 
of C. neoformans, CIA
After 72-96 hour incubation on Sabouraud agar at 25C, cells of 
strain CIA were collected and suspended in 250 ml acetone. The suspen­
sion was incubated at 25C under constant mixing using a magnetic stirrer. 
After 6 changes of acetone at 8 hour intervals, the cells were collected 
by centrifugation at 300 x g for 10 minutes and dried dm vacuo. Ten gm 
of dried cells were suspended in distilled water (10% final concentration)
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To each 20 ml of this suspension was added 20 gm of glass beads (Type 
110, Minnesota Mining and Manufacturing Co., St. Paul, Minnesota).
The mixture was placed in a Raytheon Model DF-101 sonic oscillator 
(Raytheon Manufacturing Co., Walton, Massachusetts) and treated for 
20 minutes. The supernatant fluid was collected following centrifuga­
tion at 12,000 X g for 30 minutes. Enough distilled water was added to 
the sediment to bring the total volume up to 30-35 ml and this mixture 
was sonic oscillated again for 15 minutes and centrifuged as before. 
India ink preparations of the sediment revealed that about 70-80% of the 
capsule was removed from the cells without apparent damage to the cells. 
The two supernatant fluids were pooled and treated in a manner identi­
cal to that used for the isolation of soluble polysaccharides. The 
isolated polysaccharide is hereafter referred to as adhered capsule 
from cells of CIA (ACIA).
Characterization of Polysaccharides 
Total nitrogen was determined by the micro-Kjeldahl method 
(Lang, 1958) using 4 mg samples of each polysaccharide.
Total carbohydrate was determined by the Anthrone test. A 
standard curve was obtained by using various concentrations of mannose.
For ultra centrifugal studies a Spinco Model E ultracentrifuge 
was used. Each polysaccharide was dissolved in veronal buffer (pH, 8.6; 
ionic strength, 0.15) to a final concentration of 13.3 mg/ml. The sam­
ples were centrifuged at 52,640 rpm for 90 minutes.
For serological studies an immunodiffusion technique similar 
to that of Ouchterlony (1949) was used. Diffusion plates were prepared 
as follows: A one percent solution of lonagar #2 (Colab Laboratories,
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Inc., Chicago, 111.) containing a 0.01% final concentration of merthio- 
late (Eli Lilly, Indianapolis, Indiana) was prepared in barbital buffer 
(pH 7.4). Into 10 X 10 cm plastic petri plates 15 ml of this mixture 
was poured and allowed to solidify. The plates were stored at 4C. The 
wells were punched 1.0 cm apart. Each well received approximately 0.1 ml 
of either anticryptococcal antibody (courtesy of R. F. Devlin, Depart­
ment of Microbiology, University of Oklahoma Medical Center) or antigens 
(1-2 mg/ml of purified polysaccharide, S^, SCIA, or ACIA).
Qualitative identification of monosaccharides present in each 
polysaccharide was made by descending paper chromatography on S and S 
(Schleicher and Schuell) filter paper (22.5 x 50 cm) with the following 
solvent systems: n-butanol - pyridine - O.lN HCl (5:3:2, V/V, 20 hours)
and ethyl acetate - acetic acid - formic acid - water (18:3:1:4, V/V,
18 hours). The latter was used only to elicit a better separation of 
xylose and ribose. Samples were prepared by dissolving 0.5 mg of poly­
saccharide in 0.5 ml of distilled water and 0.5 ml of 3 N HCl. The 
mixture was placed in a sealed screw capped test tube and hydrolyzed in 
boiling water for 3 hours. The sample was then dried in vacuo over NaOH, 
resuspended in 1.0 ml of distilled water, dried again, and resuspended 
0.05-0.1 ml of distilled water. The entire sample was applied to the 
paper. The standards used with each run consisted of galactose, glucur­
onic acid, glucuronolactone, glucose, mannose, ribose, and xylose. Mon­
omers were detected with 2 aminobiphenol reagent (Gordon, Thornburg, and 
Werum, 1956) or anilin-phthalic acid reagent (Wilson, 1959).
Further qualitative characterization of ACIA, SCIA, and poly­
saccharides was carried out using gas liquid chromatography. For this
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purpose, trimethylsilyl (TMS) derivatives of the hydrolized polysaccha­
rides were prepared. Ten mg of each polysaccharide, as well as 10.0 mg 
of standard containing 2.5 mg galactose, glucuronic acid, mannose and 
xylose were hydrolyzed in 1.5N HCl for 6 hours. The hydrolysates were 
dried overnight ^  vacuo over NaOH, resuspended in distilled water, and 
dried again. The TMS derivatives were prepared according to the method 
of Sweeley, _et al. (1963). A Varian Aerography gas chromatograph 
(Model 1740-1) with a six foot x 1/8 inch column packed with 3% SE-30 
mesh Varaport 30 (Varian Aerograph, Houston, Texas) was used. It was 
operated at 175C with a nitrogen flow of 30 ml/rain. A hydrogen flame 
detector was used to detect the compounds coming off the column.
Quantitative determination of each polysaccharide monomer was 
done in the following manner: Differential hydrolysis of polysaccha­
rides was accomplished by dissolving 0.5 mg or 1.5 mg samples in 0.5 ml 
or 1.5 ml of distilled water and 0.5 ml or 1.5 ml of 3N HCl, as described 
previously. Samples were hydrolyzed for 0.5, 1.0, 2.0, 4.0, 6.0, 8.0,
10.0 and 24 hours, dried in -vacuo, .resuspended .in. distilled water, dried, 
and resuspended in 0.05-0.2 ml of distilled water. Samples containing 
0.5 mg of polysaccharide were applied as spots on the chromatographic 
paper, while those containing 1.5 mg were applied as a band 5 cm in 
length. Chromatograms were run in n-butanol - pyridine - O.IN HCl sol­
vent for 20 hours and dried. Those containing 0.5 mg samples were 
stained with anilin-phthalic acid reagent. Stained carbohydrate spots 
( 3 x 3  cm) were cut into smaller pieces and eluted for one hour in 2.0 
ml of 0.7N HCl in 80% ethanol. The supernatant fluid was removed and 
read in a Beckman DU at 360 my (for hexoses) and 420 my (for uronic acids)
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(Wilson, 1959). Chromatograms containing 1.5 mg of carbohydrates were 
not stained, but were cut into 5 x 3 cm strips which were then further 
cut into smaller pieces, added to 5 ml of distilled water, placed at 40 
for 48 hours (with occasional shaking), centrifuged at 350 x g for 30 
minutes, and then 2.0 ml samples were removed for the phenol-sulfuric 
acid test (Dubois, _et _al., 1956) for hexoses and pentoses and for the 
carbazole test (Dische, 1950) for hexuronic acid. Standard curves gal­
actose, glucose, glucuronic acid, mannose, and xylose were prepared by 
using 10-200 yg of each sugar.
Galactose oxidase was also used for quantitative measurements 
of galactose in each sample. In this case, polysaccharides were hydrol­
yzed for six hours, dried, resuspended in water (as described previously) 
and used directly with galactostat reagents (Worthington Biochemical 
Corp., Freehold, N.J.).
Collection of Human Serum and Leukocytes 
Normal human blood was collected by venipuncture, aspirated in­
to sterile tubes, and allowed to clot. The resulting serum was used to 
prepare yeast suspensions and growth medium. Serum collected in this 
manner was used within 5-24 hours after collection.
Autologous peripheral blood leukocytes were collected by the 
method of Braunsteiner, Pakesch, and Vetter (1952). Ten to 15 ml of 
venous blood was drawn into a 20 ml plastic syringe containing 100-150 
units of heparin (Liquaemin Sodium "10", Organon, Inc., W. Orange, N.J.). 
Immediately, 4-6 ml of a 3.5% solution of polyvinylpyrrolidine (Type 
NP-K30) in saline was added to the blood and gently mixed. The syringe 
was then placed at a 45° angle at 4C in a beaker and the supernatant
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fluid in the syringe was aspirated very carefully into a 13 x 100 mm 
siliconized tube containing 50 units of heparin. The number of leuko­
cytes in the suspension was determined by standard hemocytometer counts. 
The viability of the leukocytes was determined with trypan blue. Gen­
erally, 95% of the leukocytes were viable and the concentration of 
leukocytes varied from 3.8 x 10^ to 4.5 x 10^ cells/ml.
Phagocytosis System
One ml of human serum containing 5-6 x 10^ yeast cells and a
1.0 ml suspension of autologous human leukocytes were placed in each 
13 X 100 mm siliconized tube. The tubes were placed at approximately 
a 30° angle on the rotator in a 37C incubator. After 90 minutes in­
cubation a drop of the mixture from each tube was placed on a micro­
scope slide, spread with another slide to an area of one square inch, 
dried, and stained with Wright-Giemsa stain. With each slide, 100 leu­
kocytes containing yeast cells was determined. The number of leukocytes 
containing yeast cells per one hundred leukocytes counted is hereafter 
referred to as the percent phagocytosis.
Phagocytosis of Cells of C_. neoformans Incubated 
in "Normal" Human Lung ^  Vitro
"Normal" human lung was obtained from the office of the Oklahoma 
State Medical Examiner. The lung tissue was obtained from a 65 year old 
man who had died as the result of a gunshot wound in the stomach 5 hours 
previously.
3
To 0.5 cm portions of tissue in 13 x 100 mm siliconized test 
tubes was added 1.5 ml of saline containing 1-2 x 10^ cells/ml of a 48 
to 72 hour culture of nonencapsulated cells of CIA. The tubes were
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incubated on a rotator at 37C. After 0, 3, 7, 11, 18, and 24 hours,
0.2 ml of fluid was transferred to a 13 x 100 mm siliconized tube con­
taining 1.0 ml of serum and 1.0 ml of the autologous leukocyte sus­
pension. After incubation on the rotator at 370 for 90 minutes the per­
cent phagocytosis was determined as described previously. Controls for 
this experiment consisted of tubes containing nonencapsulated cells of 
CIA, 1.0 ml of serum, 1.0 ml of autologous leukocytes, and 0.85 mg/ml 
of isolated ACIA capsular polysaccharide.
Capsule production was detected in buffered India ink pre­
parations.
Phagocytosis of Cells of £. neoformans
Incubated in Human Serum ^  Vitro
One tenth ml of a saline suspension containing 6-7 x 10^ non­
encapsulated cells of C^. neoformans, CIA, was added to siliconized tubes 
(13 X 100 mm) containing 0.9 ml of human serum. After 0, 2, 6, 11, and 
24 hours, 1.0 ml of autologous leukocyte suspension was added to each 
tube. Phagocytosis experiments were initiated and the percent phagocyto­
sis were determined as described previously. Control tubes contained
1.0 ml of serum containing 6-7 x 10^ nonencapsulated cells of C_. neofor­
mans, 1.0 ml of autologous leukocytes, and 0.85 mg/ml of isolated ACIA.
Location and Nature of Factor Responsible for the Inhibition 
of Phagocytosis of Cells of jC. neoformans 
Incubated in Serum for 24 Hours
To determine whether the inhibition of phagocytosis of cells 
of _C. neoformans, CIA, incubated in serum was due to soluble or adhered 
polysaccharide, the following experiments were carried out (Figure 1).
For each experiment, the leukocytes and serum were derived from the
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normal human serum + nonencapsulated CIA cells
incubate at 37C 
for 24 hours
centrifuge
r
supernatant 
(0 serum)
fresh (F) CIA cells 
and autologous 
leukocytes in plasma
sediment 
(0 cells)
+
fresh (F) serum 
and autologous 
leukocytes in plasma
incubate at 
37C for 90 
minutes
incubate at 
37C for 90 
minutes
Wright-Giemsa stain Wright-Giemsa stain
Figure 1— Assay procedure for determining location of factor 
responsible for the inhibition of phagocytosis of C^. neoformans by human 
leukocytes in vitro.
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blood of single donor. Four tubes, each containing 2.0 ml of human serum, 
were inoculated with 7.5 x 10^ cells/ml of nonencapsulated cells of _C. 
neoformans. These tubes, plus a tube containing 8.0 ml of uninoculated 
serum, hereafter referred to as fresh (F) serum, were incubated on the 
rotator at 37C for 24 hours. The contents of the tubes containing cells 
of C^. neoformans were pooled and centrifuged at 200 x g for 30 minutes.
The sediment is hereafter referred to as old (0) cells and the superna­
tant as old (0) serum. Four ml of 0 serum was passed through a 0.45y 
millipore filter and was used for chemical and immunological studies 
(see below). The remaining 4.0 ml were used for phagocytosis studies.
To each of five siliconized tubes (13 x 100 mm) was added 1.0 ml of 
either F or 0 serum. To the 0 serum was added 0.1 ml of saline contain­
ing 6.0-7.0 X 10^ cells of fresh (F) nonencapsulated yeast cells (cul­
tured for 48-72 hours on LpH agar). To the F serum was added 0.1 ml 
of saline containing 6,0-7.0 x 10^ 0 cells. Controls consisted of 1.0 
ml of 0 serum and 6.0-7.0 x 10^ 0 cells; 1.0 ml of F serum and 6.0-7.0 
X 10^ F cells; and 1.0 ml of F serum, 6.0-7.0 x 10^ F cells, and 0.85 
mg/ml of ACIA. To each tube was added 1.0 ml of autologous leukocytes. 
Phagocytosis experiments were initiated and the percent phagocytosis 
was determined as described previously.
Immunological Detection of Capsular 
Polysaccharide in Old Serum
Hyperimmune anticryptococcal rabbit sera were obtained from 
R. F. Devlin, Department of Microbiology, University of Oklahoma Medical 
Center. The rabbits had been immunized with zeolite treated antigens 
of CIA. The agglutination titer of pooled sera was greater than 1:640
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when turbidity of the antigen used was 2 McFarland units (Devlin, 1969). 
To 5.0 ml of the rabbit anticryptococcal serum was added 4.0 mg of ACIA. 
The mixture was incubated at 37C for one hour, refrigerated at 4C over­
night, and the precipitate was removed by centrifugation at 350 x g for 
10 minutes. Since, when it was used in a ring test (Campbell, et al., 
1964), additional antibody was detected in the supernatant fluid, the 
absorption was carried out 2 more times using 2.5 mg and 0.5 mg of 
antigen, respectively. At this time, the ring test indicated a very 
slight antigen excess. This absorbed and the nonabsorbed anticrypto­
coccal sera were used to examine the 0 serum for the presence of cap­
sular polysaccharide. For this purpose, 0.1 ml of 0 serum was layered 
over 0.1 ml of either absorbed or nonabsorbed sera in small test tubes. 
The tubes were incubated at 37C for 60 minutes and for the presence of 
a precipitin band was recorded arbitrarily as +++, ++, +, +, - (strong 
to no band, respectively).
Chemical Detection of Capsular 
Polysaccharide in Old Serum
Two ml of old serum was diluted with 18 ml of distilled water. 
To this solution were added 4.0 ml of 2% ZnSO^. 7H2O and 4.0 ml of 1.8% 
Ba (OH)g. 8H^0. The solution was mixed well and then centrifuged at 
350 X g for 10 minutes at 4C. The supernatant fluid was dialyzed at 4C 
against 3 changes of tap water and 3 changes of distilled water and 
then lyophilized. The lyophilized material was resuspended in 1.0 ml 
of distilled water. The presence of hexuronic acid was measured by 
the carbazole test (Dische, 1950). The standard curve for the carbazole 
test was prepared by adding the following amounts of purified capsular
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material (ACIA) to 1.0 ml of serum and treating each sample as described 
previously; 0.00 (blank), 0.25, 0.5, 1.0, 1.5, 2.0, and 2.5 mg. All 
samples were read in the Beckman DU Spectrophotometer at 535 mp.
Removal of Factor from Human Serum Responsible 
for Inhibition of Phagocytosis
To determine whether fresh, nonencapsulated cells of _C. neo­
formans could remove all or any of the inhibitory factor produced by 
cells of _C. neoformans incubated in serum, the protocol in Figure 2 
was used. Nonencapsulated cells of £. neoformans, strain CIA, were 
incubated in 4.0 ml of human serum as described previously for phago­
cytosis experiments. After 24 hours incubation at 37C, the mixture 
was centrifuged at 200 x g for 30 minutes and the supernatant fluid
9
was collected. To 3.0 ml of this fluid was added 1-2 x 10 fresh (F) 
(48-72 hour culture) nonencapsulated cells of C^. neoformans. The mix­
ture was incubated for 10 minutes at 37C on a rotator, after which it 
was centrifuged at 350 x g for 10 minutes. The sediment (treated cells) 
was washed 3 times with saline. Treated cells were added to 1.0 ml of 
F serum to a concentration of 5.0-6.0 x 10^ cells/ml. To the 1.0 ml 
of treated serum were added 6.0-7.0 x 10^ fresh yeast cells. Controls 
consisted of: 0 cells and 0 serum; 0 cells and F serum; F cells and
0 serum; F cells and F serum; and F cells, F serum, and 0.85 mg/ml 
ACIA. Each tube received 1.0 ml of autologous leukocytes. Phagocy­
tosis experiments were initiated and the percent phagocytosis was 
determined as described previously.
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normal human serum + nonencapsulated CIA cells
incubate at 
37C for 24 hours
centrifuge
4'
supernatant
I
sediment
(0 serum) (0 cells)
+
Fresh (F) yeast cells
incubate at
37C for 10 minutes
centrifuge
supernatant 
(Treated Serum)
+
Fresh (F) yeast 
cells and isolated 
autologous leuko­
cytes in plasma
incubate at 
37C for 90 
minutes
sediment 
(Treated cells)
Wash 3 times 
with 0.85% NaCl
centrifuge
supernatant
Discard
Wright-Giemsa stain
1
sediment
+
Fresh (F) serum 
and autologous 
leukocytes in plasma
incubate at 
37C for 90 
minutes
Wright-Giemsa stain
Figure 2— Procedure for removal of factor from human serum 
responsible for inhibition of phagocytosis.
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Comparison of _C. neoformans. Strains CIA 
and Mutant, by Phagocytosis
Cells of strains CIA and S^, cultured on Sabouraud agar at 25C 
for 3-5 days, were diluted in normal human serum to a final concentra­
tion of 6.0-7.0 X 10^ cells/ml. Tubes containing 1.0 ml of serum with 
either S^  or CIA cells received either 0.5 ml of saline, 0.5 ml saline 
containing 4.0 mg/ml of ACIA, 0.5 ml saline containing 4.0 mg/ml of 
soluble CIA polysaccharide (SCIA), 0.5 ml saline containing 4.0 mg/ml 
soluble S^ polysaccharide, or 0.5 ml of saline containing 4.0 mg/ml of 
capsular polysaccharide of C_. laurentii (courtesy of Dr. D. S. Feingold, 
University of Pennsylvania, Philadelphia, Pa.). Each tube received 1.0 
ml of autologous leukocyte suspension. Phagocytosis experiments were 
initiated and the percent phagocytosis was determined as described pre­
viously.
Effect of Various Treatments of"^ C^ . neoformans 
on Phagocytosis by Human Leukocytes
Forty-eight to 72 hour cultures of C_. neoformans, CIA, grown 
on LpH agar at 2 6C were harvested and treated in the following manner: 
(1) a heavy suspension of cells was prepared in 5.0 ml of saline and 
autoclaved for 15 minutes at 121C under 15 lb. pressure; (2) a heavy 
suspension of cells was prepared in 5.0 ml of 0.25% sodium desoxycholate 
(DOC) and incubated at 37C for 20 minutes. The suspension was centri­
fuged at 300 X g for 10 minutes and the sediment was washed three times 
with saline. These cells were used immediately in phagocytosis experi­
ments; (3) a heavy suspension of yeast cells was prepared in 50 ml of 
acetone, incubated for eight hours at 25C with constant mixing (using 
a magnetic stirrer). Cells were collected by centrifugation and
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resuspended in 50.0 ml of fresh acetone. This procedure was repeated 
at least 6 times and the cells were then dried ^  vacuo ; (4) a heavy 
suspension of cells was prepared in saline containing 0.6% formalin 
and stirred on a magnetic stirrer for 48 hours. Cells were collected 
by centrifugation at 300 x g for 10 minutes, washed in 0.85% NaCl, 
and stored at 4C in 0.85% NaCl containing 0.3% formalin. At the time 
of use cells were washed four times with saline. The viability of 
cells from all four treatments was determined by culturing a sample 
on Sabouraud agar. Only the DOC-treated cells could be cultured.
Trypan blue preparation of DOC-treated cells showed that 40-50% of the 
cells were viable. To each of 5 siliconized test tubes was added 1.0 
ml of serum containing 5.0-6.0 x 10^ untreated, autoclaved, DOC-treated, 
acetone-treated, or formalin-treated cells. Each tube received 0.5 ml 
of saline. A second set of 5 tubes was prepared in a similar manner 
except each tube received 0.5 ml of saline containing 2.0 mg of ACIA.
To all tubes was added 1.0 ml of autologous leukocyte suspension. Phag­
ocytosis experiments were initiated and the percent phagocytosis was 
determined as described previously.
CHAPTER III 
RESULTS 
Soil Studies
Table 5 contains the data obtained from a preliminary study 
on the effect of soil incubation on cells of strain CIA. During the 
first 30 days of incubation in soil, there was an increase in the num-
7 7
her of viable cells from 0.79 x 10 to 4.2 x 10 . The number of cells 
remained rather constant (approximately 4 x 10^) for the next 270 days 
and then decreased to 2.8 x 10^ cells after 500 days incubation in 
soil.
At the time of inoculation into soil, 100% of the cells poss­
essed capsules with an average capsular diameter of 4.Ip. After 30 
days incubation in soil the percent of nonencapsulated cells increased 
from zero to 66. The average capsular diameter of the remaining cells 
decreased from 4.Ip to 2.5p. The percent of nonencapsulated cells 
reached a maximum of 93% after 100 days incubation in soil. The average 
capsular diameter of encapsulated cells decreased to 1.7p during this 
time period. The percent nonencapsulated cells and the average capsular 
diameter of encapsulated cells remained essentially constant for the 
remainder of the experiment (500 days).
During the 500 days of incubation in soil, there was a reduc­
tion in the diameter of the cells, as well as in the diameter of the 
capsules. Initially, the average diameter of cells (excluding the
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TABLE 5
EFFECT OF SOIL INCUBATION ON THE SIZE OF CELLS, CAPSULE, 
AND VIABILITY OF C^. NEOFORMANS, CIA
Incubation
Time
(Days)
Viable Cell 
Count Per 
5.0 gm Soil
X 10'
Percent
Nonencapsulated
Cells
Average 
Diameter 
of Cells 
(w)
Average Capsule 
Diameter of 
Encapsulated 
Cells (y)
0 0.79 0.0 5.2 4.1
30 4.20 66.0 4.2 2.5
70 4.20 88.0 3.7 2.2
100 5.40 93.0 3.7 1.7
160 4.30 88.0 3.6 1.9
300 3.70 90.0 3.3 1.6
500 2.80 91.0 3.2 1.8
-p-
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capsule) was 5.2p. After 70 days of incubation, the diameter of the 
cells decreased to 3.7p. After 500 days incubation, the average 
diameter of the cells was 3.2y.
From the results of this preliminary study it appeared that 
during soil incubation cells of £. neoformans remain viable, however 
there is a reduction in the diameter of the cells and capsules and a 
marked increase in the number of nonencapsulated cells.
In further studies, 8 different strains of C_. neoformans were 
incubated in soil for 18 months. The results of this experiment are 
shown in Figure 3. During the first 2 months of incubation, there was 
approximately a two fold increase in the number of viable cells. The 
number of viable cells remained constant for the next 7 months and then 
slowly decreased. The average diameter of the cells decreased from 
4.2y to 3.2p during the 18 months of incubation in soil.
After 5 days incubation in soil (Figure 4), the percent of 
nonencapsulated cells increased from 5 to 45. After 60 days of incu­
bation in soil 85% of the cells were nonencapsulated. The percentage 
of nonencapsulated cells remained constant throughout the remainder of 
the experiment (540 days).
To determine whether the disappearance of capsule during soil 
incubation was due to a dehydration phenomenon, cells of CIA which had 
been incubated in soil for one year were suspended in distilled water 
and then used without further treatment, with chloroform treatment, or 
after autoclaving, as previously described. Initially, the percent en­
capsulated cells was 13. After 17 hours of incubation in high pH syn­
thetic broth (HpH), Sabouraud broth, distilled water, or O.lM glucose
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containing various concentrations of dinitrophenol (DNP), the percent 
of encapsulated cells was determined. Ninety-three, 91 and 63 percent 
of untreated cells were encapsulated in HpH, Sabouraud broth, and dis­
tilled water, respectively. At the lowest concentration of DNP (1 x 
•“6
10 M), the percent encapsulation of untreated cells was about 70. In
-4
the highest concentration of DNP (1 x 10 M) only 30 percent of the 
cells were encapsulated. The chloroform treated or autoclaved cells 
shows no increase in the percent encapsulated cells in any of the media 
used.
Effect of Soil Incubation on 
Virulence of C_. neoformans
After 0, 1, 6, 12, and 18 months incubation in soil, 1.0 ml 
of soil washings containing 0.79-4.3 x 10^ cells were inoculated intra- 
peritoneally (I.P.) into each of 5 mice. All mice died within four 
weeks after inoculation and had symptoms of cryptococcal meningitis.
Large, encapsulated yeast cells were observed in brain tissues at autopsy. 
C^. neoformans was isolated in pure culture from brain tissues of the in­
fected mice. At the dosage used, there was no apparent reduction in 
virulence of the organisms during 18 months of incubation in soil.
Effect of Water on Capsular Production 
by C_. neoformans Incubated in Soil
The effect of water on capsular production by cells of C^. neo­
formans incubated in soil for one year was determined by adding various 
amounts of water to 5 gm soil samples containing the cells of strain 
CIA. The results are presented in Figure 5. There was no apparent in­
crease in percent of encapsulated cells in the soil sample treated with
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0.5 ml of water. However, there was a direct relationship between the 
amount of water added and percent encapsulation in the range of 1.0 -
4.0 ml of water. The control samples, i.e., those autoclaved before the 
addition of water, demonstrated no increase in the percent of encapsu­
lated cells.
Generation Time Studies of C. neoformans
When cells of CIA grown on Sabouraud agar were transferred into 
HpH broth, there was a lag period of at least 2 hours before the cells 
entered the logarithmic phase. The culture reached the stationary phase 
approximately 18 hours after inoculation. The generation time of the 
cells was 2.5 hours. Whereas, cells maintained in soil for one year 
had a 4 hour lag period when subsequently inoculated into HpH broth. 
During logarithmic phase which lasted approximately 18 hours, the gen­
eration time was 2.5 hours. Thus, the only difference in the growth 
cycles of the two types of cells was the longer lag period for cells in­
cubated in soil.
Capsule Production by Nonencapsulated 
Cells of neoformans
Following cultivation on low pH synthetic agar (LpH) at 26C 
for 3-5 days, 90-95% of the cells of strain CIA are nonencapsulated. 
These cells were incubated in phosphate buffer (pH 5.0) overnight to 
reduce the endogenous metabolites and used to evaluate the effects of 
various compounds on capsule production (Figure 6). In the medium 
lacking carbohydrates no capsule was detected after 22 hours incubation. 
When glucose and ammonium sulfate were added, capsule production was 
observed during the first hour of incubation. After 8 hours incubation
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approximately 65% of the cells were encapsulated and after 22 hours over 
90% of the cells possessed capsules. During the initial 16 hours of in­
cubation capsule production was almost as rapid with resting cells (i.e., 
cells in medium containing glucose but lacking ammonium sulfate) as with 
actively proliferating cells (i.e., cells in medium containing glucose 
and ammonium sulfate). After 22 hours incubation, 80% of the resting 
cells were encapsulated and 93% of the actively proliferating cells were 
encapsulated.
The addition of various concentrations of thiamine (0.0 - 10.0 
Ug/ml) to the media had no effect on the production of capsule during 
22 hours incubation.
When DNP was added to medium containing glucose but no ammonium 
sulfate, the percent encapsulation was reduced from approximately 80 
to less than 30. Sodium fluoride or potassium iodoacetate failed to 
inhibit capsule production.
Effect of Different Carbohydrates on Capsule 
Production of Resting Cells by C_. neoformans
The ability of nonencapsulated resting cells of CIA to utilize 
carbohydrates for capsular production was studied. The carbohydrates 
chosen were those found as monomers in the capsular polysaccharide of 
C^. neoformans, i.e. galactose, glucuronic acid (sodium salt), mannose, 
and xylose. Glucose was used as a control. After 18 hours incubation 
70-76% of the cells were viable regardless of the media (Table 6).
Capsule production occurred in the presence of all the carbohydrates 
but not in the medium lacking a source of carbon. Cells having the 
largest capsule, as well as largest percent encapsulation, were those
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TABLE 6
EFFECT OF VARIOUS CARBOHYDRATES ON CAPSULE PRODUCTION
BY RESTING CELLS OF C. NEOFORMANS, CIA*
Carbohydrate
Percent
Encapsulation
Diameter of 
Capsule (p)
Percent
Viability
Galactose 65 2.1 75
Sodium Glucuronate 48 1.6 70
Mannose 70 3.8 71
Xylose 43 1.2 76
None 9 1.0 75
Glucose (control) 76 2.5 75
^Measurements were made after 18 hours of incubation at 25C. 
Initially only 7% of the cells were encapsulated.
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incubated in mannose. Cells having the smallest capsule, as well as the 
smallest percent encapsulation, were those incubated in xylose and glu­
curonic acid.
pH Optimum for Capsular Production by 
Resting Cells of C_. neoformans
Different buffers were used to study the pH optimum for cap­
sular production. Using Walpole's acetate buffer (pH 3.6-5.6) inhibited 
capsule production by cells of CIA. Thus, Mcllvaine's phosphate buffer 
(pH 2.2-8.0) was used for this study. After two hours incubation at 25C, 
maximum number of encapsulated cells was observed between pH 4.2 and 
5.4 (Figure 7). About 40-43% of the cells had capsules. The average 
capsule diameter of the encapsulated cells was 1.5y between pH 3.4 and 
7.4.
After 24 hours incubation at 25C, the optimal pH range shifted 
to slightly higher values. Maximum capsular production was observed in 
the pH range 6.2-7.0. In this pH range, 77% of the cells possessed cap­
sules. The average capsular diameter of encapsulated cells was approxi­
mately 3.Ou between pH 3.0 and 5.2, 4.Op between pH 5.6 and 6.8, 3.Op 
between pH 7,2 and 7.6, and l.Op at the higher pH levels. The trypan 
blue dye test revealed that 75% of the cells were viable in all tubes 
(pH 3.0-8.2) after 24 hours incubation.
Ability of C_. neoformans to Degrade 
Cryptococcal Capsule
The ability of C_. neoformans to utilize its own capsule was 
tested by inoculating nonencapsulated CIA cells into 50 ml of Bacto- 
Yeast Nitrogen Base supplemented with 1.0 mg/ml of isolated capsular
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material (ACIA) as a sole source of carbon. At various times, the via­
bility of the cells and the amount of nondialyzable polysaccharide pre­
sent in the culture filtrate were determined. After 2 days incubation 
at 25c under aeration, cell numbers increased from 0.30 x 10^ to 1.2 x 
10^ per ml. The number of cells increased to 2.0 x 10^/ml during the 
remainder of the study (28 days). The amount of polysaccharide pre­
sent in the culture filtrate decreased from 1.0 mg to 0.9 mg/ml within 
the first 2 days of incubation and remained almost constant for the 
duration of study.
Effect of Various Inorganic Salts on
Capsular Production of C^. neoformans
In preliminary experiments using cells of CIA grown on either 
LpH (nonencapsulated cells) or Sabouraud agar (encapsulated cells) and 
various concentrations of NaCl it was found that with Increasing con­
centration of NaCl, the percent encapsulation decreased. Cells grew 
well in 5% NaCl but not in 10% NaCl. The data obtained from a more 
extensive study are presented in Table 7. Six encapsulated strains of 
C^. neoformans cultured on HpH agar were inoculated into HpH or Sabouraud 
broths containing 5% concentrations of various salts. All six strains 
demonstrated a decreased ability to produce capsules in the salt solu­
tions. In general, after two transfers into the salt solutions the
percent encapsulation dropped to an average of 10. In the presence of
NaCl, KHgPO^, and KgHPO^, all strains studied demonstrated less than
7% encapsulation. With NaNO^ and KCl, all strains tested, with the ex­
ception of CS, demonstrated 10% encapsulation or less. In the presence 
of Na2S0  ^and K^SO^, all strains tested demonstrated 16% encapsulation
TABLE 7
EFFECT OF INORGANIC SALTS ON CAPSULAR PRODUCTION 
BY SIX STRAINS OF C. NEOFORMANS
Salts
Strain
CIA A
Percent Encapsulation 
B CDC CS UH^
None 1 0 0 95 82 98 84 99
NaCl 1 0 5 3 4 0
NaNOg 0 1 0 3 1 28 8
Na^SO^ 1 4 16 6 51 1 1
K 2 SO4 1 5 1 0 1 54 32
KCl 3 I 1 0 1 14 0
KHgPO^ 0 5 6 0 1 0
K 2 HPO4 2 0 4 1 1 0
Ln
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or less, with the exception of CS (51% and 54%, respectively) and UH^
(32% encapsulation in the presence of K2S0^).
Effect of Lactose on Capsular 
Production of C_. neoformans
The results obtained during 7 days incubation of cells of CIA 
in HpH broth with various concentrations of lactose are shown in Figure 
8. Capsular production decreased as lactose concentration increased. 
After several days, cells in all concentrations of lactose demonstrated 
less than 30% encapsulation. There was a slower increase in growth 
(turbidity) in cultures containing 30 and 40% lactose than in the others.
Capsular Production by C_. neoformans 
on Various Laboratory Media
The ability of C_. neoformans to produce a capsule on various 
laboratory media was studied using nutrient agar (NA), trypticase soy 
agar (TSA), Sabouraud agar, potato-dextrose agar (PDA), HpH, and Paper's 
complete agar. Table 8 contains the results of this study. With ex­
ception of CDC, none of the strains produced any visible capsules on 
NA and TSA. All of the strains produced varying amounts of capsule on 
all of the mycological media used. In general, the cells produced the 
largest capsules on PDA medium.
Capsular Production by £. neoformans 
in Mouse Tissue ^  Vitro
The ability of nonencapsulated cells of CIA to produce capsules 
when incubated in mouse blood, brain, and lung tissues was studied.
After 24 hours incubation, the capsule diameter and percent encapsulated 
cells was less in the tubes containing lung or brain tissue in saline
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TABLE 8
CAPSULAR PRODUCTION BY EIGHT STRAINS OF
ON VARIOUS LABORATORY MEDIA*
NEOFORMANS
Medium Potato- Raper's
Nutrient Trypticase Sabouraud Dextrose Complete
Strain Agar Soy Agar HpH Agar Agar Agar Agar
A - - + + ++ +
B - - + + ++ -H-+-
CDC - + ++ -H- +++ 4-H-
CIA - - + + ++ +
CS - - ++ -H- -H-4- +++
CSIO - - ++ ++ ++ ++
UHi - - 4- + -H- +
UH^ — — + + ++ +
no capsular production; +, not all cells possess capsules and the average capsular diame—
ter of encapsulated cells was less than 2 y ; +, most cells were encapsulated with average capsular dia-
ONo
meter of 4.0-4.5p; ++, most cells were encapsulated with average capsular diameter of 4.5-5.Op; +++, 
most cells were encapsulated with average capsular diameter of more than 5p.
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than in all other combinations (Table 9). The addition of blood to these 
tubes resulted in an increase in capsule diameter and percent encapsula­
tion. After 66 hours incubation, only the cells suspended in brain and 
saline had a capsule diameter less than 4.Op.
Isolation and Characterization of Nonencapsulated 
Mutants of C^. neoformans, CIA
Cells of CIA were inoculated into Sabouraud broth and incubated 
at 25C without aeration. At various times, samples were removed and 
examined for the presence of stable nonencapsulated mutants. Nonencap­
sulated colonies were not observed until after the first 10 days of in­
cubation. Thereafter, approximately 20 nonencapsulated colonies were 
isolated. Four of these organisms were chosen for further study and 
hereafter are referred to as S^ , S^, S^, and S^ . All four strains had 
the following characteristics in common:
1. Ability to utilize galactose, glucose, maltose, and sucrose, 
but not lactose, as a sole source of carbon.
2. Inability to utilize nitrate as a sole nitrogen source.
3. Ability to produce urease.
4. Ability to grow at 37C.
All four isolates varied in their ability to produce capsules 
and in virulence for mice (Table 10). Whereas and did not pro­
duce capsules under any circumstances, and were avirulent for mice, 
produced capsules most of the time and was virulent for mice. was 
intermediate in these characteristics. It did not produce capsules on 
laboratory media and when it was inoculated intraperitoneally, it was 
avirulent for mice. However, when it was inoculated intracerebrally it
TABLE 9
CAPSULAR PRODUCTION BY £. NEOFORMANS, CIA, 
IN MOUSE TISSUE IN VITRO
Incubation Time (Hours)
Constituents of 
Each Tube
0
CD^ PE^
18
CD PE
24
CD PE
48
CD PE
66
CD PE
Blood + Brain + Minimal 
Broth 1.0 5 4.2 95 4.2 95 4.2 95 4.2 95
Blood + Lung + 0.85% NaCl 1.0 5 2.8 92 3.5 95 4.0 95 4.0 95
Lung + 0.85% NaCl 1.0 5 1.25 65 1.0 70 2 . 8 95 4.0 95
Blood + Brain + 0.85% NaCl 1.0 5 2 . 8 92 3.0 92 4.0 95 4.0 95
Brain + 0.85% NaCl 1.0 5 2.3 60 2.5 63 2.5 95 3.0 95
Minimal Broth 1.0 5 4.0 95 4.0 95 4.0 95 4.0 95
N3
Average capsular diameter of encapsulated cells In microns.
Percent encapsulated yeast cells.
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TABLE 10
CHARACTERISTICS OF C. NEOFORMANS. CIA,
AND MUTANTS S^ S^  and
Organism
Characteristic CIA
^1 ^2 '3 ^
Capsule + -
Growth at 37C + + + + +
I F ^
Virulence
+ - - +
I.e. + + +
^Produced capsule in vivo (I.e. inoculation) but not in vitro.
Segregated into encapsulated and nonencapsulated colonies, but 
eventually reverted to the encapsulated state.
c
I.p. = intraperitoneal
I.e. = intracerebral
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killed mice. The mice died after a longer incubation period (2-4 weeks) 
than those inoculated with the parental strain (1 week). Examination 
of brain tissue revealed the presence of encapsulated yeast cells. How­
ever, upon inoculation of brain tissue on Sabouraud agar, the cell iso­
lates were nonencapsulated. Using mouse tissues suspended in saline or 
in broth (the same type of experiment as with CIA reported previously) 
and the S^, S^ , and mutants, it was found that in the presence of 
brain, blood, or lung tissues, or combinations of these tissues, none 
of the mutants was able to produce visible capsules after 96 hours in­
cubation.
In further studies of the mutants, their ability to grow in 
the presence of the monomers of cryptococcal capsule, i.e. galactose, 
glucuronic acid, mannose, and xylose, was examined. All of the mutants 
grew in the presence of any one, or combination of these carbohydrates, 
but under no circumstances did they produce visible capsules.
Transformation studies using dead encapsulated cells of the 
CIA strain and viable nonencapsulated mutants (S^, S ,^ and S )^ were 
negative. Two days post inoculation, a few (less than 10) nonencapsu­
lated colonies were isolated from tissue homogenates of inoculated mice. 
No organisms were isolated from the infected animals thereafter. None 
of the animals showed any symptoms of cryptococcosis, i.e. bulging of 
cranium, or tumor-like masses in the liver and kidney, during the course 
of the experiment (20 days).
Characterization of Isolated Polysaccharides
Soluble polysaccharides of S^, S^ , and CIA (SCIA) cells and 
adhered capsular polysaccharide of CIA (ACIA) were isolated by alcoholic
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treatment of culture broths. The characteristics of the materials are 
shown in Table 11. The amount of protein, as determined by the micro- 
Kjeldahl method, was 1.2% or less. Nucleic acids, as determined by specto- 
photometric readings at 260 and 280 my and by paper chromatography, 
were present in trace amounts. At no time, were ribose or deoxyribose 
detected by chromatography of acid hydrolysates of these polysaccha­
rides. The amount of carbohydrate present was determined by the An- 
throne test, using mannose as a standard. contained 55.0%, con­
tained 57.0%, SCIA contained 56.0%, and ACIA contained 66.5% carbohy­
drate assuming the capsule was made of pure mannan. The purity of S^ ,
SCIA, and ACIA polysaccharides was determined by ultra centrifugation 
technique. All three polysaccharides exhibited a single peak with cal­
culated sedimentation coefficients of 1.265, 1.365, and 1.385, respec­
tively. The molecular weight of these polysaccharides was estimated 
to be between 10,000 and 15,000.
On double diffusion plates, ACIA produced one very strong pre­
cipitin band, with possibly a weak second band when it was reacted with 
anticryptococcal antibody. SCIA and S^ polysaccharides produced three 
precipitin bands. All three bands demonstrated partial identity with 
the strong band of ACIA.
Qualitative paper chromatography of an acid hydrolysate of each 
of the three polysaccharides indicated the presence of galactose, glu­
curonic acid, glucuronolactone, mannose, and xylose. Gas-liquid chroma­
tography revealed the presence of the same monomers (Figure 9) except 
that it was difficult to determine whether or not galactose was present 
in ACIA, although it was detected in S^ and SCIA. Galactose was detected
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TABLE 11
QUALITATIVE ANALYSIS OF POLYSACCHARIDES ISOLATED 
FROM PARENTAL STRAIN CIA AND MUTANTS S, AND S,
Type of 
Polysaccharide*
% Total 
Protein
% Total 
Nucleic Acid
% Total 
Carbohydrates
Si
<1.0 Trace 55.0
S2 <1.0 Trace 57.0
SCIA 1.2 Trace 56.0
ACIA <1.0 Trace 66.5
*S^ and Sg soluble polysaccharides isolated from HpH culture 
broths of S^ and S^ mutants.
SCIA - Soluble polysaccharide isolated from HpH culture broths 
of CIA strain.
ACIA - Adhered capsular polysaccharide isolated by sonic os­
cillation from CIA cells cultured on Sabouraud agar.
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Known Carbohydrates.
68
with galactose oxidase in all three polysaccharides.
The rate of release of monomers during acid hydrolysis was 
similar in all polysaccharides. Maximum amounts of xylose were released 
within the first 3 hours, and the release of galactose reached a peak 
after 8 hours of hydrolysis. With ACIA, maximum amounts of glucuronic 
acid and glucuronolactone were detected after 6 hours of hydrolysis.
The release of glucuronic acid and glucuronolactone from and SCIA 
was detected after 8 hours of hydrolysis.
The data from quantitative paper chromatography, using either 
the phenol sulfuric acid test or the aniline-phthalic acid stain, are 
shown in Table 12. The molar ratio of mannose to xylose to glucuronic 
acid to galactose was (9:4:3:2) found to be identical in the soluble 
polysaccharides (S^ and SCIA). ACIA appeared to contain slightly more 
glucuronic acid.
Phagocytosis Studies
When cells of CIA grown on Sabouraud agar (large capsules) were 
used for phagocytosis studies i^ vitro, about 25% of the peripheral 
blood leukocytes phagocytized these cells. When cells of CIA grown on 
LpH medium (very small capsules) were used, about 79% of the leukocytes 
phagocytized them. This indicated, as was shown by Bulmer and Sans 
(1968), that capsular polysaccharide inhibits phagocytosis of cells of CIA.
Phagocytosis of Nonencapsulated C^. neoformans 
Incubated with Human Lung Tissue ^  Vitro
Nonencapsulated cells of CIA grown on LpH agar were transferred 
into tubes containing small pieces of excised human lung tissue and sa­
line. With increasing incubation time in human lung tissue from zero
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TABLE 12
QUANTITATIVE STUDIES OF ACIA, SCIA, 
AND S^ POLYSACCHARIDES
Type of 
Polysaccharide Mannose Xylose
Molar Ratio
Glucuronic Acid Galactose
ACIA 9.0 4.0 3.5 2.0
SCIA 9.0 4.0 3.0 2.0
Si
9.0 4.0 3.0 2.0
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to 24 hours, the percent encapsulation Increased from 5% to 80%. At the 
same time, the percent phagocytosis decreased (Figure 10). After 5-10 
hours incubation in. human lung tissue the percent phagocytosis was in­
hibited by 50%. The bar on the right (control) represents the percent 
phagocytosis of nonencapsulated cells of CIA when 0.85 mg/ml of isolated 
capsular material (ACIA) was added to the system. Approximately 20 hours 
incubation in exised human lung were required for the nonencapsulated 
cells of CIA to produce enough capsule to reduce phagocytosis from 75% 
to 24%.
Phagocytosis of Nonencapsulated jC. neoformans,
Incubated in Human Serum Ir^  Vitro
Nonencapsulated cells of CIA (grown on LpH agar) were incubated 
in human serum. As the incubation time in serum increased (Figure 11) 
the percent phagocytosis decreased. It required 8-10 hours incubation 
to reduce phagocytosis by 50%. After 24 hours, the percent phagocytosis 
was reduced to 31. The bar on the right (control) represents the per­
cent phagocytosis of nonencapsulated cells of CIA when 0.85 mg/ml of 
isolated capsular material (ACIA) was added to the system. The India 
ink preparations of the cells after 24 hours incubation showed that 
less than 18% of the cells were encapsulated.
To locate the phagocytic inhibitory factor, CIA cells (0 cells) 
and serum (0 serum) were separated by centrifugation after 24 hours in­
cubation. To these were added fresh serum (F serum) and fresh cells 
(F cells), respectively. The percents phagocytosis found in these sys­
tems were as follows :
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0 cells + 0 serum, 31%
0 cells + F serum, 78%
F cells + 0 serum, 30%
F cells + F serum, 79%
F cells + F serum +0.85 mg/ml ACIA, 28%
These results indicated that the inhibitory factor was located in the 
serum rather than on the cells. Since capsular polysaccharide is anti­
phagocytic, attempts were made to detect it in the serum. Cells of CIA 
were incubated in serum and after 24 hours were removed by centrifuga­
tion. The serum was examined immunologically and chemically for the 
presence of capsule. Immunologically, the presence of capsule was mea­
sured with nonabsorbed and absorbed (purified ACIA) rabbit anticrypto- 
coccal antibody. As shown in Table 13, the sera from 4 individuals 
reacted very strongly with nonabsorbed rabbit serum, while there was 
very little, if any, reaction with absorbed serum. This indicated that 
capsular material was present in the sera. Chemically, the presence of 
capsular polysaccharide was detected by the carbazole test in which the 
presence of hexuronic acid, and to some extent xylose, was measured.
As it can be seen in Table 13, 0.58-0.66 mg of capsular material could 
be detected per ml of serum. The control represents serum which was 
not inoculated with cells of CIA.-
Bulmer and Sans (1968) reported that isolated capsular poly­
saccharide is adsorbed by fresh nonencapsulated cells of CIA. Phagocy­
tosis of the latter cells is then inhibited. To determine whether the 
inhibitory factor present in serum could be adsorbed, serum which had 
been incubated with cells of CIA for 24 hours (0 serum) was treated with
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TABLE 13
IMMUNOLOGICAL AND CHEMICAL EVIDENCE FOR CRYPTOCOCCAL 
POLYSACCHARIDE IN HUMAN SERA
Experimental
Subject
Precipitation Ring Test
Polysaccharide 
in Serum 
(mg/ml)
Nonabsorbed 
Anticrypto- 
coccal Serum
Absorbed Anti- 
cryptococcal Serum
1 +++ + 0.60
2 +-H- + 0.66
3 -H- - 0.58
4 +++ + 0.63
Control - - 0.00
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fresh cells (F cells) for ten minutes and then the fresh nonencapsulated 
treated cells (FT cells) and the serum (OT serum) were used in phagocy­
tosis studies (Figure 2). The percent phagocytosis found in these ex­
periments was as follows :
0 cells + 0 serum, 30%
F cells + F serum, 75%
F cells + 0 serum, 30%
FT cells + F serum, 44%
F cells + OT serum, 41%
It thus appears that fresh nonencapsulated cells of CIA can remove a 
substance, probably polysaccharide, from serum, since serum treated
cells were not as well phagocytized as untreated cells.
Comparative Phagocytosis Studies of £. neoformans,
Strains CIA and S^
Cells of the nonencapsulated mutant S^ were tested in phago­
cytosis experiment and the percent phagocytosis of these cells was 80. 
This mutant produces a soluble polysaccharide which is identical with 
that produced by CIA. However, when this organism was incubated in 
serum for varying periods of time, up to 24 hours, there was very 
little reduction in the percent phagocytosis (from 80 to 66). Ring 
tests, using both absorbed and nonabsorbed rabbit serum, indicated 
the presence of capsule in the serum. When nonencapsulated cells of 
CIA were incubated in the serum, phagocytosis decreased from 78% to 22%. 
Similarly, serum in which cells of CIA had been incubated for 24 hours 
reduced the phagocytosis of nonencapsulated cells of CIA from 78 to 31%, 
whereas it reduced the phagocytosis of cells of from 80% to only 70%.
A study was therefore designed to determine whether isolated cryptococcal
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polysaccharides have the same effect on phagocytosis of cells of and 
CIA. The results obtained in this type of study are presented in Table 
14. It will be seen that phagocytosis of nonencapsulated cells of CIA 
decreased to 26% with ACIA, to 39% with SCIA, and to 42% with poly­
saccharide. Phagocytosis of cells was 65% with ACIA, 70% with SCIA, 
and 71% with polysaccharide. The capsule from £. laurentii was used 
as a control to test for specificity of the £. neoformans capsule in 
inhibiting phagocytosis of CIA cells. This polysaccharide reduced the 
phagocytosis of nonencapsulated cells of CIA to 63%. Thus, it appeared 
that although phagocytosis of nonencapsulated cells of CIA was inhibited 
by _C. neoformans capsule, the latter material had little effect on phag­
ocytosis of the nonencapsulated mutant S^ .
Effect of Various Treatments of C. neoformans, CIA, 
on Inhibition of Phagocytosis by Human 
Leukocytes In Vitro
Nonencapsulated cells of CIA were treated with heat (autoclaved 
for 15 minutes), sodium desoxycholate, acetone, or formalin. Cells 
treated in each manner were used in phagocytosis studies. All of the 
cells were killed except those treated with DOC, in which case about 
50% of the cells were viable. The results are presented in Table 15. 
With nontreated cells, the percent phagocytosis was 78% in the absence 
of cryptococcal polysaccharide and 26% in its presence. When heat, 
acetone, or formalin treated cells were used there was very little, if 
any, reduction in the percent phagocytosis in the presence of capsular 
material. When DOC treated cells were used, there was approximately a 
40% inhibition of phagocytosis in the presence of capsule. It thus ap­
pears that killing or injuring the cells interferes with the inhibition 
of phagocytosis.
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TABLE 14
PHAGOCYTOSIS OF C. NEOFORMANS, STRAINS CIA
AND S., BY HUMAN LEUKOCYTES IN VITRO 1 -------
Strain
Type of 
Capsule*
Percent
Phagocytosis
CIA -- 79
S, __ 80
1
CIA ACIA 26
^1
ACIA 65
CIA SCIA 39
^1
SCIA 70
CIA
'l
42
S, S, 71
1
CIA
1
CL 63
*ACIA:
SCIA:
Sl =
CL:
Adhered CIA polysaccharide 
Soluble CIA polysaccharide 
Soluble S^ polysaccharide 
C. laurentii polysaccharide
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TABLE 15
EFFECT OF VARIOUS TREATMENTS OF C. NEOFORMANS, CIA,
ON INHIBITION OF PHAGOCYTOSIS BY
HUMAN LEUKOCYTES IN VITRO
Cells of CIA Percent
Pretreated With ACIA in NaCl NaCl Phagocytosis
_ + 78
+ 26
Heat (Autoclaved)
+
+ 75
63
Sodium
72
44
Desoxycholate
+
+
Acetone
+
+ 87
84
Formalin
+
+ 91
90
CHAPTER IV
DISCUSSION
Until recently, when Ishaq, eh al., .(1968) speculated that 
CryptoCOecus neoformans may reside in soil in a nonencapsulated state, 
it was generally accepted that C_. neoformans was found only in the en­
capsulated state and that the infectious particle consisted of an en­
capsulated yeast 10-20 microns in diameter.
In the present study, information concerning the state of C^. 
neoformans in soil was obtained using eight different strains of the 
organism. It was found that the cells remained viable in soil for at 
least 18 months. A more interesting aspect of the findings was that an 
increase in the number of nonencapsulated cells occurred during incuba­
tion in soil. The number of nonencapsulated cells increased rapidly 
during the first two months of incubation and thereafter remained fairly 
constant at 85%. It is possible that the remaining 15% encapsulated 
cells were not viable at the time of inoculation into soil, or died soon 
thereafter before losing their capsules. The loss of capsule appears 
to correlate directly with an increase in number of viable cells (Figures 
3 and 4). Evans (1960) was able to demonstrate a reduction of crypto­
coccal capsule during short term exposure to dehydrating substances.
This phenomena did not seem to apply during soil incubation because:
(1) encapsulated dead cells did not lose capsule during 18 months of soil
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incubation; (2) nonencapsulated cells, which had been incubated in soil 
for one year, did not produce capsules when they were killed before re­
moval from the soil; (3) nonencapsulated cells produced capsules only 
when actively metabolizing; and (4) capsular production is energy de­
pendent. It thus appears that both the appearance and disappearance of 
capsule require metabolizing cells, and a dehydration-rehydration phe­
nomenon is not responsible.
If the disappearance of capsule is not based on a dehydration 
phenomenon, then, it seemed possible that the cells are actually able 
to utilize their own capsule as an energy and carbon source, i.e., the 
capsule may act as an extracellular storage compartment. When isolated 
cryptococcal polysaccharide was used as the sole source of carbon for
nonencapsulated cells of C^. neoformans, the polysaccharide decreased
from 1.0 mg to 0.9 mg/ml in the culture filtrate within the first two
days of incubation. During the same period there was a four-fold in­
crease in the number of viable cells. The concentration of polysaccha­
ride did not decrease further after the first two days of incubation. 
Under the experimental conditions used, little evidence was obtained to 
substantiate this proposal, however, this phenomenon has been reported 
in other organisms. Several investigators (Davis, Rhodes, and Shulke, 
1965; Buck, et al., 1968; and Szaniszlo, Wirsen, and Mitchell, 1969) 
demonstrated degradation and utilization of polysaccharides by the or­
ganisms which produced them. Szaniszlo, ^  al., (1969) reported that 
Leptosphaeria albopunctata, a .filamentous fungus which produces a poly­
saccharide containing a large amount of glucose and a small amount of 
mannose, apparently utilized its own capsular polysaccharide.
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Since it was not apparent that cells of _C. neoformans were able 
to utilize capsular material, the effect of various salts on capsular 
production was studied. Salts, especially NaCl, affect the production 
of different macromolecules in bacterial cells, although the mechanism 
of their action is not known (Smithies, Gibbons, and Bayley, 1955;
Brown, 1961; Brown, 1964). Thus, it was not surprising to find that 
all of the salts tested in the present study inhibited capsular pro­
duction of _C. neoformans (Table 7). Since addition of water to soil 
samples initiated capsular production (Figure 5), it would appear that 
the presence of salts in soils may reduce the activity of water, thus 
inhibiting capsular production. In other words, disappearance and re­
appearance of capsule may be controlled by the amount of active water 
present in the system. To test this hypothesis, another means was used 
to reduce the water activity of the system. It has been reported that 
several species of yeasts and filamentous fungi are able to grow in 
environments of low water activity, that is in the presence of high 
sugar concentrations (Anand and Brown, 1968). Sucrose and fructose 
were used as carbohydrates of choice by these investigators. However, 
since £. neoformans utilizes these carbohydrates, but not lactose, the 
latter was used in the present investigation. It was found that £. 
neoformans is able to grow in the presence of 40% lactose in a high 
pH synthetic medium (HpH). Although the growth of the cells was slower 
in this concentration of lactose than in concentrations of 10% or less, 
there was a decrease in the number of encapsulated cells. Since salts 
and lactose diminish the water activity in a given system, it seems 
possible that the decrease in water activity may be partially responsible
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for the disappearance of capsule of _C. neoformans in soil.
Another interesting finding was the effect of soil incubation 
on the size of the cell. Concurrently, with an increase in the number 
of nonencapsulated cells, the average diameter of the cells decreased 
from 4.2y to 3.2p. The fact that the average number of nonencapsulated 
cells increased to 85% during the course of the experiment and the 
average size of the cells decreased to 3.2p indicates that the overall 
average diameter of the particles of C_. neoformans in soil is approxi­
mately 3.2y for the eight strains used in this investigation. In other 
words, the infectious particle of the organism probably resides in soil 
in a relatively small, nomncapsulated state. It has been shown (Hatch, 
1961) that the highest probability for deposition of inhaled particles 
in the respiratory spaces of the lung occurs within the size range of 
l-2y in diameter. As the particle size increases, penetration and de­
position in the lungs decreases simply because fewer particles escape 
trapping in the upper respiratory. With particles larger than lOy in 
diameter penetration into the lung is practically zero. In light of 
this, it is difficult to imagine how C_. neoformans could lodge in human 
lungs if the infectious particles are 10-20 microns in diameter, as gen­
erally accepted. Results of these investigations indicate that the 
dissemination and infectious particles are less than 4 microns in dia­
meter. If this measurement is a true reflection of all strains of C.
neoformans, it becomes much easier to accept the respiratory tract in
man as the principal portal of entry.
The loss of a capsule, and the small size of cells of £. neo­
formans in soil, would be of little significance if there were a
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simultaneous and parallel decrease in the virulence of the organism.
At the dosage used (0.79 - 4.3 x 10^ cells) there was no apparent de­
crease in the virulence of C^. neoformans isolated from soil. Ishaq 
(1965) reported a slight decrease in the virulence of one strain of C^. 
neoformans ATCC 11239. This discrepancy may be due to strain differ­
ences or to the size of the inocula used for infecting animals.
It can be postulated that the presence of salts and lack of 
water activity in soil inhibits capsular production. In addition, when 
the cells divide, the newly formed daughter cells do not possess cap­
sules. Due to as yet unknown environmental factors these cells are 
smaller in size. When the endogenous supply of carbohydrate is depleted, 
as can be demonstrated by a long (8 hour) lag phase once the organisms 
are transferred into suitable medium, the cells remain viable and viru­
lent in soil, as do the spores of other fungi and bacteria. It is in 
this state that they are probably disseminated.
If £. neoformans resides in soil in a nonencapsulated state, 
and since the importance of capsule as a virulence factor has been demon­
strated (Bulmer, eit al., 1967), the time and conditions required for 
capsular production take on a new importance. Since the isolation of 
nonencapsulated cells from the soil was not mechanically feasible, cells 
were grown on low pH synthetic medium (LpH) to inhibit capsular produc­
tion. Such nonencapsulated cells of strain CIA were able to produce 
visible capsules in the presence of glucose and essential salts. Cap­
sular production by these cells, as with those incubated in soil, was 
energy dependent, since the addition of dinitrophenol (DNP), an uncoup­
ling agent of oxidative phosphorylation (Mahler and Cordes, 1966),
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decreased the production of capsule. Thus, it appears that glucose acts 
as both a carbon and an energy source. Similar findings have been report­
ed with Diplococcus pneumoniae, which can synthesize capsular polysaccha­
ride in the resting state in the presence of glucose and salts 
(Bernheimer, 1953).
Attempts to inhibit glucose utilization by sodium fluoride (NaF) 
and potassium iodoacetate (KIAc) were unsuccessful. At the concentra­
tion levels used, these inhibitors had no effect on either the growth 
of the cells or on capsular production. It is possible that these inhi­
bitors were not able to enter the cells.
Thiamine and glutamic acid had no effect on capsular production 
by £. neoformans within the first 24 hours incubation with either rest­
ing or growing cells. Although Reid (1949) reported that C. neoformans 
requires thiamine for growth and Littman and Zimmerman (1956) showed 
that the largest amount of capsule is produced in synthetic media con­
taining glutamic acid and thiamine, it should be noted that their in­
vestigations were long term growth studies and it is very difficult to 
completely deplete the intracellular levels of these compounds in short 
term (i.e., 24 hours) studies.
The pH optimum for capsular production after 2 hours of incu­
bation was in the acidic range (4.6 - 5.8), and after 24 hours of in­
cubation maximal capsular production occurred at a more neutral pH, 
approximately 7.0.
Spontaneous nonencapsulated mutants of £. neoformans were iso­
lated from the parental encapsulated strain, CIA. At least 20 differ­
ent nonencapsulated colonies were detected but only four were chosen
85
for further studies. Although mutant strains showed the same biochemical 
pattern as the parental strain) they varied in their ability to produce 
capsules (Table 10). Mutants and did not produce capsules under 
any of the experimental conditions used, either in vivo or in vitro.
These two mutants were avirulent for mice. Mutant S ,^ on the other hand, 
produced capsules both vivo and vitro. However, the encapsulated 
cells segregated into encapsulated and nonencapsulated cells and even­
tually all of the cells had capsules, at which time this mutant behaved 
in a manner similar to that of the encapsulated parental strain.
Mutant produced capsules and killed mice when it was inocu­
lated intracerebrally, but not when it was inoculated intraperitoneally. 
Since the peritoneum contains a large number of highly active phagocy­
tes, especially after provocation, the organisms probably were phago­
cytized soon after intraperitoneal inoculation, whereas in the brain, 
with its lower phagocytic activity, the cells had sufficient time, and 
the required nutrients, to produce capsules and thereby inhibit phago­
cytosis even further. It should be mentioned that, whereas the parental 
strain, CIA, produced capsules in mouse tissue both ^  vitro and vivo, 
cells did not produce capsules in the presence of mouse tissues in 
vitro. Capsular production by cells in mouse brain vivo was not 
due to the back mutation of these nonencapsulated cells to their original 
encapsulated state since the cells of were encapsulated vivo, they 
were nonencapsulated when the infected tissue was cultured onto labor­
atory media.
Several mycological and bacteriological media were used to cul­
ture various encapsulated strains, as well as nonencapsulated mutants
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of C^. neoformans. With one exception, none of the strains produced 
capsules on bacteriological media. Thus, such media as nutrient 
agar and trypticase soy agar cannot be used to detect the presence of 
encapsulated yeasts. Whereas all of the encapsulated cells produced 
capsules on mycological media, S ,^ a virulent mutant which produces 
capsules ^  vivo, did not produce capsules on any of the bacterio­
logical or mycological media. These findings indicate that upon cul­
turing clinical specimens, £. neoformans may be encountered in either 
the encapsulated or the nonencapsulated state.
Although mutants and did not produce capsules vitro, 
they produced a soluble polysaccharide when they were cultured in a 
liquid medium. The parental strain (CIA) produced capsules, as well 
as a soluble polysaccharide, when it was cultured in liquid media. 
Soluble polysaccharides isolated from the broth cultures by ethanol 
precipitation contained galactose, glucuronic acid, mannose, and xylose. 
The fact that the polysaccharide from the mutants contained the same 
monomers as those identified in the parental strain, plus the fact that 
the mutants were able to utilize monomers of the capsule as a carbon 
source, suggest that the mutation occurred at a site which controls the 
attachment of the polysaccharide to the cell wall rather than at one of 
the sites which controls the interconversion of the sugars.
Further chemical and serological studies of and soluble CIA 
(SCIA) polysaccharides showed them to be identical. There was a slight 
difference between soluble polysaccharides (S^ and SCIA) and capsular 
polysaccharide (ACIA) of the parental strain. This difference, was de­
tected both serologically and chemically. Serologically, the soluble
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polysaccharides showed three precipitation bands on double diffusion 
plates, while ACIA demonstrated one very strong precipitation band, 
and possibly a second band. It should be noted that the three pre­
cipitation bands of the soluble polysaccharides were partially identi­
cal with that of ACIA. Chemically, ACIA contained a larger amount of 
glucuronic acid. This suggests that glucuronic acid may play a role
in attachment of polysaccharide to the yeast cells. S^, SCIA, and
ACIA polysaccharides had similar sedimentation coefficients in the 
ultracentrifuge. Under the conditions used, the molecular weights of 
these polysaccharides were estimated to be between 10,000 and 15,000.
Differential hydrolysis of Type A cryptococcal capsular poly­
saccharide (ACIA), as well as the soluble (SCIA) and S^ polysaccharides, 
indicated that mannose was liberated slowly from the polysaccharide, 
while xylose was liberated rapidly, suggesting that xylose is located 
on the external side chains of the polysaccharide and that mannan forms 
the backbone.
While the same monomers, galactose, glucuronic acid, xylose, 
and mannose, were found in Type B cryptococcal capsular polysaccharide 
(Blandamer and Danishefsky, 1966), the molar ratios of these monomers 
varied with the different serologic types of cryptococcal polysaccharide.
The molar ratio of mannose to xylose to glucuronate to galac­
tose was 6:4:2:1 in Type B polysaccharide (Blandamer and Danishefsky, 
1966), whereas it was 9:4:3:2 in Type A soluble polysaccharide and 
9:4:3.5:2 in Type A adhered polysaccharide. These findings support the 
hypothesis proposed by Evans and Mehl (1951) that the type specificity 
of cryptococcal polysaccharide is due to quantitative rather than
qualitative differences in the monomers.
The results of vitro phagocytosis studies of _C. neoformans 
in its encapsulated and nonencapsulated states, using human peripheral 
leukocytes, once more emphasized the importance of the capsule as an 
antiphagocytic substance. The results of phagocytosis studies in which 
nonencapsulated cells of C_. neoformans were incubated with human lung 
tissue indicated that, after 5-10 hours incubation, enough capsular 
polysaccharide is produced to inhibit phagocytosis by 50%. As the in­
cubation time in lung tissue increased, the percent encapsulation of 
the yeast cells increased and the percent phagocytosis decreased. Within 
24 hours, enough capsule was present to inhibit phagocytosis by 64% 
(Figure 10). During incubation in serum, the same pattern of inhibition 
of phagocytosis was detected. Although phagocytosis was not inhibited 
as much as in lung tissue, the percent phagocytosis was reduced by about 
60% after 24 hours incubation in serum (Figure 11). However, few encap­
sulated cells were observed in India ink preparation. It then became 
of interest to determine whether phagocytosis was inhibited by a sub- 
stance(s) that was produced by the cells and adsorbed to them, but which 
could not be visualized microscopically, or a substance(s) produced by 
the cells and excreted into the serum. Further studies indicated that 
the material was produced by the cells and excreted into the serum. 
Chemical and immunological studies of the serum revealed the presence 
of cryptococcal polysaccharide (Table 13). Thus, it appears that whereas 
visible capsular polysaccharide seemed to be responsible for inhibition 
of phagocytosis in lung tissue, soluble polysaccharide was the responsi­
ble factor in serum.
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The soluble polysaccharide responsible for the inhibition of pha­
gocytosis apparently must attach itself to the yeast cells to be effective 
(see below). If this is so, then one wonders why the cells incubated in 
serum for 24 hours, centrifuged, washed, and suspended in fresh serum did 
not inhibit phagocytosis. One explanation for such a finding may be that 
during the repeated washing the polysaccharide was eluted from the cells 
and therefore was not present during the actual phagocytosis experiments.
Although soluble polysaccharide can inhibit phagocytosis, and 
the mutant can produce a soluble polysaccharide quite similar to that 
of SCIA, the former organism was not virulent for mice. One possibility 
is that this organism is able to produce soluble polysaccharide vitro 
only on suitable media. However, whereas incubation of these cells in 
human serum for 24 hours did not inhibit phagocytosis of cells, immun­
ological studies (precipitin ring test) with the serum revealed the pre­
sence of capsular material. Although the serum had no inhibitory effect 
on phagocytosis of cells, it inhibited the phagocytosis of CIA cells. 
Further, serum which had been incubated with CIA cells inhibited the 
phagocytosis of this strain of C_. neoformans, but it had no inhibitory 
effect on phagocytosis of the strain. The reason for this might have 
been that (1) cells of the strain adhered together more so than the 
cells of the CIA strain, thus allowing for better surface phagocytosis 
or (2) a "receptor site", i.e., point of attachment of polysaccharide to 
the yeast cell, was missing or altered on the surface of the cells.
It was shown by Bulmer and Sans (1968) that isolated polysaccharide ad­
heres to cryptococcal cells and thus inhibits phagocytosis. In the pre­
sent study, it was shown that fresh, nonencapsulated cells of CIA are
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able to remove portions of the inhibitory factor from the serum which 
had been incubated with CIA for 24 hours. These findings support the 
hypothesis that the mutation occurred at a locus which is involved 
in the formation of the receptor sites. If the cells contained recep­
tor sites which are the point of attachment for the capsule, it seems 
possible that they could be destroyed. The results presented in Table 
15 indicate that killing the cells under certain conditions alters the 
ability of the capsule to inhibit phagocytosis. Thus, the receptor site 
hypothesis seems to be the most feasible and satisfactory explanation 
for the high degree of capsular specificity.
It now seems possible to correlate some of the information al­
ready known about neoformans with that obtained from these investiga­
tions and suggest a mechanism for the pathogenesis of cryptococcosis.
The infectious particle of _C. neoformans is probably a nonencapsulated 
yeast less than 4 microns in. diameter. Without its capsule, dissemi­
nation of the organism by air currents would be greatly facilitated.
This concept also makes it easier to accept the respiratory tract as 
the portal of entry, since few particles over five microns in diameter 
are capable of entering the human lung (Hatch, 1961).
Once in the lungs, the organism is probably phagocytized and 
killed (Bulmer and Sans, 1967; Bulmer and Sans, 1968; Bulmer, et al., 
in preparation) or destroyed by serum factors (Baum and Artis, 1961;
Baum and Artis, 1963; Bulmer, e^ , in preparation; Igel and Bolande, 
1966; Szilagyl, Reiss and Smith, 1966; Zimmerman and Rappaport, 1954).
It seems possible that certain individuals develop cryptococcosis be­
cause of an underlying deficiency of their immunological system. Such
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a deficiency, induced either naturally or artifically (Bennington,
Haber, and Morgenstern, 1964; Brunning, Foley and Fortuny, 1963), could 
afford adequate time for capsular production, which in turn would in­
hibit phagocytosis. In other instances, individuals may inhale a large 
enough dose of yeast cells to create a locus in the lung. The time re­
quired to remove all of these cells would allow some of them to produce 
enough capsular material to inhibit phagocytosis. From in vitro studies, 
it appears that 5-10 hours are required for nonencapsulated cells to 
produce enough capsule to inhibit phagocytosis by 50%. Thus, the size 
of the inoculum, and more importantly, the speed at which the cells are 
able to produce capsules vivo appear to be of primary importance to 
the pathogenesis of cryptococcosis.
CHAPTER V
SUMMARY
Encapsulated cells of eight strains of C^. neoformans remained 
viable in soil during 18 months of incubation. Eighty-five percent of 
the cells lost their capsules within the first two months of incubation 
and remained nonencapsulated thereafter. The disappearance of the cap­
sule was not due to dehydration. Actively metabolizing cells were re­
quired for disappearance and reappearance of capsule. Capsular syn­
thesis seemed to be controlled by the amount of available water present. 
Due to as yet unknown factors, the size of the cells, as well as the 
size of the capsule, decreased during 18 months of incubation in soil.
Under suitable conditions, capsular synthesis by environmentally 
induced nonencapsulated cells was initiated in one hour. Capsular pro­
duction was demonstrated in both growing and resting cells of £. neofor­
mans. It was not observed in the absence of a carbon and/or energy 
source. Salts in excess of 5% inhibited capsular production. The op­
timum pH for initial capsular production (after 2 hours incubation) by 
resting cells of C^. neoformans was 4.0 - 5.8. After 24 hours incuba­
tion, the largest amount of capsule was produced at pH 6.2 - 7.0. No 
capsular production was observed below pH 3.0 or above pH 8.0.
None of the. genetically induced mutants produced capsules
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vitro. One of them, S^, produced capsules in vivo when it was inoculated 
intracerebrally into mice, and it was virulent for mice when injected 
I.e. This mutant, however, was not virulent when it was inoculated 
intraperitoneally. The other mutants were avirulent for mice regard­
less of the route of inoculation.
Although the nonencapsulated mutants did not produce adhered 
polysaccharide (capsule) i^ vitro, they produced a soluble polysaccha­
ride when cultured in synthetic broth (pH 7.0). Adhered and soluble 
polysaccharides were isolated by ethanol precipitation of either super­
natant fluid of the sonic oscillated encapsulated cells or broth cul­
tures of the encapsulated parental strain or nonencapsulated mutant 
strains. Qualitatively, both adhered and soluble polysaccharides con­
tained galactose, glucuronic acid, mannose, and xylose. Soluble poly­
saccharides isolated from mutant and parental CIA cells were serolo­
gically and chemically identical. With both materials, molar ratio for 
mannose to xylose to glucuronic acid to galactose were 9:4:3:2. Adhered 
polysaccharide from parental CIA cells contained slightly more glucuronic 
acid than did the soluble polysaccharides. The percent molar ratio of 
the adhered polysaccharide was mannose, 9; xylose, 4; glucuronic acid, 
3.5; and galactose, 2. The results of differential hydrolysis of solu­
ble and adhered polysaccharides suggested that these polysaccharides 
contained a mannan backbone with xylose at the external ends of the 
branches.
Phagocytosis studies confirmed the fact that cryptococcal poly­
saccharides inhibit the phagocytosis of the organism by human leukocytes. 
The inhibitory action of polysaccharide seems to depend upon the direct
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attachment of the macromolecule onto the yeast cells rather than a 
direct effect on the leukocytes. Experimental data are presented to 
suggest the presence of specific attachment sites for the polysaccha­
ride on the yeast cells. In human lung tissue or in serum, five to 
eight hours were required for environmentally induced nonencapsulated 
cells of _C. neoformans to produce enough capsule to inhibit phagocyto­
sis by 50%.
In summary, C_. neoformans cells remain viable in soil without 
apparent loss of virulence for more than 18 months. The cells lose 
capsules within the first two months of incubation in soil. The average 
diameter of the cells decreases to less than five microns. It is 
postulated that dissemination and inhalation of the organism by indivi­
duals are thereby facilitated and that, once in the tissue of a sus­
ceptible host, capsule production is initiated. The capsule is a 
polysaccharide composed of mannose, xylose, glucuronic acid, and gal­
actose and it inhibits the phagocytosis of the organism by human leu­
kocytes. The antiphagocytic nature of the polysaccharide is very speci­
fic and is directed towards yeast cells that have compatible receptor 
sites. Whereas all virulent strains of C_. neoformans produce capsules 
in vivo, they may not do so vitro.
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